MCID: STN013
MIFTS: 25

Stenotrophomonas Maltophilia Infection

Categories: Nephrological diseases, Rare diseases

Aliases & Classifications for Stenotrophomonas Maltophilia Infection

MalaCards integrated aliases for Stenotrophomonas Maltophilia Infection:

Name: Stenotrophomonas Maltophilia Infection 52
Stenotrophomonas Maltophilia 52
S. Maltophilia Infection 52
S. Maltophilia 52

Classifications:



Summaries for Stenotrophomonas Maltophilia Infection

NIH Rare Diseases : 52 Stenotrophomonas maltophilia (S. maltophilia ) infection is a type of bacterial infection. S. maltophilia is found mostly in wet environments. In the hospital setting, S. maltophilia can be found in fluids, such as irrigation solutions (fluids used to clean a wound or wash out a body cavity like the ear canal or bladder) and intravenous (IV) fluids , as well as patient secretions, such as mucus from the respiratory tract and urine. The bacteria causes problems mainly in people who have a weakened immune system . To cause infections in healthy people, S maltophilia must bypass the normal human defenses, as can happen with the use of certain medical devices, such as catheters or IV lines. People who are hospitalized and receiving treatment for other serious medical conditions may be more susceptible to an infection, especially if their immune system is weakened. Symptoms vary depending on the area of the body infected. Diagnosis of S. maltophilia infection, along with other bacterial infections, may be suspected by symptoms and risk factors . A culture of body fluids, such a blood , urine , sputum , or abdominal fluid , is used to confirm the specific type of bacteria. A consultation with an infectious disease specialist is important to differentiate bacterial colonization (where the bacteria are found in the body but do not cause symptoms) from an infection and to determine the best treatment options.

MalaCards based summary : Stenotrophomonas Maltophilia Infection, also known as stenotrophomonas maltophilia, is related to meningitis and leukemia, acute myeloid. The drugs Azithromycin and Bronchodilator Agents have been mentioned in the context of this disorder. Affiliated tissues include colon, testes and lung.

Wikipedia : 74 Stenotrophomonas maltophilia is an aerobic, nonfermentative, Gram-negative bacterium. It is an uncommon... more...

Related Diseases for Stenotrophomonas Maltophilia Infection

Diseases related to Stenotrophomonas Maltophilia Infection via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 155, show less)
# Related Disease Score Top Affiliating Genes
1 meningitis 10.6
2 leukemia, acute myeloid 10.6
3 cystic fibrosis 10.5
4 neutropenia 10.5
5 infective endocarditis 10.5
6 osteomyelitis 10.5
7 myeloid leukemia 10.5
8 48,xyyy 10.5
9 myelodysplastic syndrome 10.4
10 bacterial infectious disease 10.4
11 respiratory failure 10.4
12 scleritis 10.4
13 thrombocytopenia 10.4
14 septic arthritis 10.4
15 pyomyositis 10.4
16 fibrosis of extraocular muscles, congenital, 1 10.4
17 cellulitis 10.4
18 retinal detachment 10.3
19 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.3
20 mucositis 10.3
21 hypopyon 10.3
22 orbital cellulitis 10.3
23 pleural empyema 10.3
24 corneal ulcer 10.3
25 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.3
26 endocarditis 10.3
27 acute cystitis 10.3
28 toxic shock syndrome 10.3
29 conjunctivitis 10.3
30 peritonitis 10.3
31 lung disease 10.3
32 dacryoadenitis 10.3
33 dacryocystitis 10.3
34 pars planitis 10.3
35 graft-versus-host disease 10.3
36 leukemia, acute lymphoblastic 3 10.3
37 mulchandani-bhoj-conlin syndrome 10.3
38 mastitis 10.3
39 discitis 10.3
40 acute leukemia 10.3
41 paronychia 10.3
42 diarrhea 10.3
43 liver cirrhosis 10.3
44 congestive heart failure 10.3
45 end stage renal failure 10.3
46 cholangitis 10.3
47 fungal keratitis 10.3
48 overgrowth syndrome 10.3
49 thrombophilia due to thrombin defect 10.1
50 pituitary hormone deficiency, combined, 2 10.1
51 pulmonary disease, chronic obstructive 10.1
52 aplastic anemia 10.1
53 leukemia, acute lymphoblastic 10.1
54 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 10.1
55 purpura fulminans 10.1
56 childhood acute lymphocytic leukemia 10.1
57 lymphocytic leukemia 10.1
58 ecthyma 10.1
59 cholestasis 10.1
60 purpura 10.1
61 uremia 10.1
62 endophthalmitis 10.1
63 pneumonia 10.1
64 cataract 10.1
65 47,xyy 10.1
66 autoimmune disease 10.1
67 aortic valve disease 1 10.1
68 congenital anomalies of kidney and urinary tract 2 10.1
69 renal cell carcinoma, nonpapillary 10.1
70 leukemia, chronic lymphocytic 10.1
71 myositis 10.1
72 enterocolitis 10.1
73 immune deficiency disease 10.1
74 myelofibrosis 10.1
75 ocular motor apraxia 10.1
76 yemenite deaf-blind hypopigmentation syndrome 10.1
77 sickle cell anemia 10.1
78 ovarian hyperstimulation syndrome 10.1
79 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.1
80 malaria 10.1
81 melioidosis 10.1
82 helix syndrome 10.1
83 swine influenza 10.1
84 lung abscess 10.1
85 dextro-looped transposition of the great arteries 10.1
86 polycystic kidney disease 10.1
87 corneal disease 10.1
88 meningoencephalitis 10.1
89 glucose intolerance 10.1
90 blind loop syndrome 10.1
91 corneal edema 10.1
92 hydronephrosis 10.1
93 acute conjunctivitis 10.1
94 epidural abscess 10.1
95 heart disease 10.1
96 diphtheria 10.1
97 corneal abscess 10.1
98 acute endophthalmitis 10.1
99 allergic hypersensitivity disease 10.1
100 dengue disease 10.1
101 shigellosis 10.1
102 klebsiella pneumonia 10.1
103 necrotizing ulcerative gingivitis 10.1
104 dumping syndrome 10.1
105 pneumothorax 10.1
106 neovascular glaucoma 10.1
107 pericarditis 10.1
108 keratopathy 10.1
109 colon adenocarcinoma 10.1
110 transverse colon cancer 10.1
111 dermatitis 10.1
112 acute pancreatitis 10.1
113 gingivitis 10.1
114 hyper ige recurrent infection syndrome 1 10.1
115 central nervous system disease 10.1
116 liver disease 10.1
117 pyoderma 10.1
118 myopathy 10.1
119 macular retinal edema 10.1
120 infertility 10.1
121 aortic valve insufficiency 10.1
122 bronchitis 10.1
123 lymphopenia 10.1
124 acquired immunodeficiency syndrome 10.1
125 acute disseminated encephalomyelitis 10.1
126 compartment syndrome 10.1
127 acute canaliculitis 10.1
128 appendicitis 10.1
129 influenza 10.1
130 whipple disease 10.1
131 arthritis 10.1
132 herpes simplex 10.1
133 nervous system disease 10.1
134 decubitus ulcer 10.1
135 diabetic macular edema 10.1
136 otitis externa 10.1
137 bacterial meningitis 10.1
138 bronchiectasis 10.1
139 fasciitis 10.1
140 necrotizing fasciitis 10.1
141 stomatitis 10.1
142 chronic dacryocystitis 10.1
143 acute myeloblastic leukemia without maturation 10.1
144 granulocytopenia 10.1
145 haemophilus influenzae 10.1
146 mycobacterium chelonae 10.1
147 polymyositis 10.1
148 stevens-johnson syndrome/toxic epidermal necrolysis 10.1
149 head injury 10.1
150 headache 10.1
151 inflammatory myopathy with abundant macrophages 10.1
152 necrotizing soft tissue infection 10.1
153 argyria 10.1
154 rare surgical neurologic disease 10.1
155 keratitis, hereditary 9.9

Graphical network of the top 20 diseases related to Stenotrophomonas Maltophilia Infection:



Diseases related to Stenotrophomonas Maltophilia Infection

Symptoms & Phenotypes for Stenotrophomonas Maltophilia Infection

Drugs & Therapeutics for Stenotrophomonas Maltophilia Infection

Drugs for Stenotrophomonas Maltophilia Infection (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 6, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azithromycin Approved Phase 2 83905-01-5 55185 447043
2 Bronchodilator Agents Phase 2
3 Pharmaceutical Solutions Phase 1, Phase 2
4
Ceftaroline fosamil Approved, Investigational Phase 1 229016-73-3
5 Anti-Bacterial Agents Phase 1
6 Anti-Infective Agents Phase 1

Interventional clinical trials:

(showing 7, show less)
# Name Status NCT ID Phase Drugs
1 Phase II, Randomized, Double Blind, Placebo-Controlled Trial of Azithromycin in Patients With CF, Chronically Infected With Burkholderia Cepacia Complex Unknown status NCT00298922 Phase 2 Azithromycin;Placebo
2 Diagnostic Utility of Induced Sputum Using Hypertonic Saline to Evaluate Airway Infection and Inflammation in Cystic Fibrosis Completed NCT00721071 Phase 2 Hypertonic Saline
3 Post Marketing Study of Anti-pseudomonas IgY in Prevention of Recurrence of Pseudomonas Aeruginosa Infections Infections in Cystic Fibrosis (CF) Patients Completed NCT00633191 Phase 1, Phase 2 Anti-pseudomonas IgY gargle
4 Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance Completed NCT03025841 Phase 1 Ceftaroline
5 Clinical Characteristics and Microbiology of Healthcare Associated Pneumonia Completed NCT01966796
6 Resistance Pattern of Gram-negative Bacteria Isolated From Blood From HSCT Recipients. Completed NCT02257931
7 Pneumonia Due to Stenotrophomonas Maltophilia in Intensive Care Units: a Multicentre Retrospective Study Active, not recruiting NCT03506191

Search NIH Clinical Center for Stenotrophomonas Maltophilia Infection

Genetic Tests for Stenotrophomonas Maltophilia Infection

Anatomical Context for Stenotrophomonas Maltophilia Infection

MalaCards organs/tissues related to Stenotrophomonas Maltophilia Infection:

40
Colon, Testes, Lung, Bone, Liver, Bone Marrow, Skin

Publications for Stenotrophomonas Maltophilia Infection

Articles related to Stenotrophomonas Maltophilia Infection:

(showing 2365, show less)
# Title Authors PMID Year
1
Twitching motility of Stenotrophomonas maltophilia under iron limitation: In-silico, phenotypic and proteomic approaches. 61
31957553 2020
2
Sustainability potentials of novel laccase tinctures from Stenotrophomonas maltophilia BIJ16 and Bordetella bronchiseptica HSO16: From dye decolourization to denim bioscouring. 61
31886141 2020
3
Characterization of an efficient estrogen-degrading bacterium Stenotrophomonas maltophilia SJTH1 in saline-, alkaline-, heavy metal-contained environments or solid soil and identification of four 17β-estradiol-oxidizing dehydrogenases. 61
31780289 2020
4
Understanding the interdependence of strain of electrotroph, cathode potential and initial Cu(II) concentration for simultaneous Cu(II) removal and acetate production in microbial electrosynthesis systems. 61
31722262 2020
5
Effect of Neotype Rectal Mild Hypothermia Therapy on Intestinal Bacterial Translocation in Rats with Hypoxic-Ischemic Brain Damage. 61
32017761 2020
6
Characterization of an 17β-estradiol-degrading bacterium Stenotrophomonas maltophilia SJTL3 tolerant to adverse environmental factors. 61
31834439 2020
7
Persistent colonization of non-lymphoid tissue-resident macrophages by Stenotrophomonas maltophilia. 61
31630178 2020
8
Stenotrophomonas maltophilia infections: Clinical characteristics in a military trauma population. 61
31791809 2020
9
Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance. 61
31843689 2020
10
Adhesion of Pseudomonas aeruginosa, Achromobacter xylosoxidans, Delftia acidovorans, Stenotrophomonas maltophilia to contact lenses under the influence of an artificial tear solution. 61
31973583 2020
11
Mutations in Ribosomal Protein RplA or Treatment with Ribosomal Acting Antibiotics Activates Production of Aminoglycoside Efflux Pump SmeYZ in Stenotrophomonas maltophilia. 61
31712205 2020
12
Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole. 61
31748318 2020
13
Complete Genome Sequence of Stenotrophomonas Phage Mendera. 61
31896654 2020
14
Assessment of a Loop-Mediated Isothermal Amplification (LAMP) Assay for the Rapid Detection of Pathogenic Bacteria from Respiratory Samples in Patients with Hospital-Acquired Pneumonia. 61
31940771 2020
15
Isolation and Identification of Arsenic-resistant Bacteria for Possible Application in Arsenic Bioremediation. 61
31930884 2020
16
Multicenter surveillance of the epidemiology of gram-negative bacteremia in Japan. 61
31932213 2020
17
Stenotrophomonas Bacteremia Antibiotic Susceptibility and Prognostic Determinants: Mayo Clinic 10-Year Experience. 61
32016126 2020
18
Amelioration effect of chromium-tolerant bacteria on growth, physiological properties and chromium mobilization in chickpea (Cicer arietinum) under chromium stress. 61
31893290 2020
19
Treatment of multidrug-resistant Gram-negative skin and soft tissue infections. 61
32022742 2020
20
Isolation, characterization and inoculation of Cd tolerant rice endophytes and their impacts on rice under Cd contaminated environment. 61
32018197 2020
21
Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia. 61
31941869 2020
22
Clonal Diversity, Biofilm Formation, and Antimicrobial Resistance among Stenotrophomonas maltophilia Strains from Cystic Fibrosis and Non-Cystic Fibrosis Patients. 61
31906465 2020
23
Impact of Chronic Obstructive Pulmonary Disease on Incidence, Microbiology and Outcome of Ventilator-Associated Lower Respiratory Tract Infections. 61
31979375 2020
24
High Direct Bilirubin Associated With Levoffoxacin Use in a Neonate. 61
31897078 2020
25
Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients. 61
31505224 2020
26
Complete Genome Sequence of Stenotrophomonas maltophilia Myophage Moby. 61
31896658 2020
27
Stenotrophomonas maltophilia susceptibility to ceftazidime-avibactam combination versus ceftazidime alone. 61
32014291 2020
28
Influence of surface copper content on Stenotrophomonas maltophilia biofilm control using chlorine and mechanical stress. 61
31997661 2020
29
Phosphoglycerate mutase affects Stenotrophomonas maltophilia attachment to biotic and abiotic surfaces. 61
31430538 2020
30
Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during polymicrobial airway infections. 61
31932329 2020
31
Degradation kinetics of carbendazim by Klebsiella oxytoca, Flavobacterium johnsoniae, and Stenotrophomonas maltophilia strains. 61
31912400 2020
32
Pediatric tracheostomy: epidemiology and characterization of tracheal secretion - a literature review. 61
31994633 2019
33
The dishwasher rubber seal acts as a reservoir of bacteria in the home environment. 61
31856722 2019
34
Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials. 61
31451421 2019
35
Carbon selection for nitrogen degradation pathway by Stenotrophomonas maltophilia: Based on the balances of nitrogen, carbon and electron. 61
31520854 2019
36
First report of survival in two patients with hematologic malignancy and Stenotrophomonas maltophilia hemorrhagic pneumonia treated with trimethoprim-sulfamethoxazole-based combination antibiotic therapy. 61
31882384 2019
37
Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity. 61
31846104 2019
38
In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017. 61
31843999 2019
39
Successful application of CytoSorb® hemadsorption in an immunocompromised teenager with collapsing glomerulopathy, acute respiratory distress syndrome, and sepsis. 61
31277560 2019
40
An investigation of Stenotrophomonas maltophilia-positive culture caused by fiberoptic bronchoscope contamination. 61
31864284 2019
41
Growing resistance in Stenotrophomonas maltophilia? 61
31789358 2019
42
In Vitro Activities of β-Lactam-β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory Pathogens. 61
31611364 2019
43
Genomic information on Stenotrophomonas maltophilia ST264 isolated from a cystic fibrosis pediatric patient in Brazil. 61
31858443 2019
44
Replacement of the Native Mitral Valve Due to Endocarditis Caused by Stenotrophomonas Maltophilia. 61
31719013 2019
45
Medical Management of Endocarditis Caused by Stenotrophomonas maltophilia: A Case Report. 61
29575970 2019
46
In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018. 61
31427295 2019
47
The Synthesis and Characterization of PEG-SH-Modified Gold Nanoparticle in One-Pot Synthesis by Stenotrophomonas maltophilia. 61
31039886 2019
48
Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia. 61
31369109 2019
49
Stenotrophomonas maltophilia Gd2: A potential and novel isolate for fibrinolytic enzyme production. 61
31762628 2019
50
Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections. 61
31427300 2019
51
Isolation and characterization of novel bacterial strain present in a lab scale hybrid UASB reactor treating distillery spent wash. 61
29726742 2019
52
Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin. 61
31724042 2019
53
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria. 61
31724045 2019
54
Biosynthesis of bismuth selenide nanoparticles using chalcogen-metabolizing bacteria. 61
31642950 2019
55
Preparation and characterization of photocatalytic Gd-doped TiO2 nanoparticles for water treatment. 61
30864042 2019
56
Investigation of chlorine tolerance profile of dominant gram negative bacteria recovered from secondary treated wastewater in Jaipur, India. 61
31739205 2019
57
Risk factors and antimicrobial resistance profiles of Pseudomonas putida infection in Central China, 2010-2017. 61
31689866 2019
58
Endophytic bacteria of desert cactus (Euphorbia trigonas Mill) confer drought tolerance and induce growth promotion in tomato (Solanum lycopersicum L.). 61
31442862 2019
59
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections. 61
31724043 2019
60
Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital. 61
31691173 2019
61
Prolonged exposure of Stenotrophomonas maltophilia biofilms to trace levels of clofibric acid alters antimicrobial tolerance and virulence. 61
31265978 2019
62
The clinical impact of Stenotrophomonas maltophilia bacteremia on the 30-day mortality rate in patients with hematologic disorders: a single-institution experience. 61
31686323 2019
63
Phlegmonous gastritis in a patient with mixed-phenotype acute leukemia in the neutropenia phase during chemotherapy: A case report. 61
31702630 2019
64
Stenotrophomonas maltophilia biofilm: its role in infectious diseases. 61
31658838 2019
65
Microbiology and clinical characteristics of industrial oil burns. 61
31761453 2019
66
Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome. 61
31682878 2019
67
Imaging findings of Stenotrophomonas maltophilia pneumonia: emphasis on CT findings between immunocompromised and immunocompetent patients. 61
31698928 2019
68
Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study. 61
31752976 2019
69
TonB-dependent uptake of β-lactam antibiotics in the opportunistic human pathogen Stenotrophomonas maltophilia. 61
31773806 2019
70
Physiological and proteomic analysis of Stenotrophomonas maltophilia grown under the iron-limited condition. 61
31777284 2019
71
Evaluation of the Treatment of Stenotrophomonas maltophilia in Tracheostomy-Dependent Pediatric Patients. 61
31719813 2019
72
Author Correction: BsmR degrades c-di-GMP to modulate biofilm formation of nosocomial pathogen Stenotrophomonas maltophilia. 61
31594958 2019
73
Quantitative real-time PCR assay for the rapid identification of the intrinsically multidrug-resistant bacterial pathogen Stenotrophomonas maltophilia. 61
31617838 2019
74
Comparative In Vivo Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against Stenotrophomonas maltophilia in the Murine Thigh Model. 61
31591126 2019
75
Molecular Basis of Class A β-Lactamase Inhibition by Relebactam. 61
31383664 2019
76
Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis. 61
31289826 2019
77
Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: Systematic review. 61
31130079 2019
78
Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy. 61
31187401 2019
79
Stenotrophomonas skull base osteomyelitis presenting as necrotizing otitis externa: Unmasking by CT and MRI-case report and review. 61
31462947 2019
80
Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al. 61
31680042 2019
81
Complete Genome Sequence of Stenotrophomonas Phage Pokken. 61
31624175 2019
82
Direct-from-blood RNA sequencing identifies the cause of post-bronchoscopy fever. 61
31660864 2019
83
Stenotrophomonas maltophilia Encodes a VirB/VirD4 Type IV Secretion System That Modulates Apoptosis in Human Cells and Promotes Competition against Heterologous Bacteria, Including Pseudomonas aeruginosa. 61
31235638 2019
84
The first report on the in vitro antimicrobial activities of extracts of leaves of Ehretia serrata. 61
31516355 2019
85
Synthesis and Bioactivities of New Membrane-Active Agents with Aromatic Linker: High Selectivity and Broad-Spectrum Antibacterial Activity. 61
31328496 2019
86
In Vivo Pharmacodynamic Study of Cefiderocol, a Novel Parenteral Siderophore Cephalosporin, in Murine Thigh and Lung Infection Models. 61
31262762 2019
87
GINGIVAL ULCERATIONS IN A PATIENT WITH ACUTE MYELOID LEUKEMIA: A case report and literature review. 61
31969772 2019
88
Cluster endophthalmitis due to Stenotrophomonas maltophilia following intravitreal bevacizumab: outcomes of patients from North India. 61
30420442 2019
89
Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis-data from the European cystic fibrosis society patient registry. 61
31492646 2019
90
Complete Genome Sequence of Stenotrophomonas maltophilia Podophage Ponderosa. 61
31558640 2019
91
Stenotrophomonas maltophilia: More than Just a Colonizer! 61
31645832 2019
92
The opportunistic pathogen Stenotrophomonas maltophilia utilizes a type IV secretion system for interbacterial killing. 61
31513674 2019
93
Prevalence of antibiotic resistance and integrons, sul and Smqnr genes in clinical isolates of Stenotrophomonasmaltophilia from a tertiary care hospital in Southwest Iran. 61
31579442 2019
94
Genome data of Stenotrophomonas maltophilia DF07 collected from polluted river sediment reveals an opportunistic pathogen and a potential antibiotic reservoir. 61
31304216 2019
95
Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains. 61
31462215 2019
96
Overexpression of SmeGH contributes to the acquired MDR of Stenotrophomonas maltophilia. 61
31086945 2019
97
Rare case of implantable cardioverter defibrillator infection caused by Stenotrophomonas maltophilia and Pantoea calida. 61
31471361 2019
98
Detection of blaCTX-M15 and blaOXA-48 genes in Gram-negative isolates from neonatal sepsis in central of Iran. 61
31719958 2019
99
Stenotrophomonas maltophilia Differential Gene Expression in Synthetic Cystic Fibrosis Sputum Reveals Shared and Cystic Fibrosis Strain-Specific Responses to the Sputum Environment. 61
31109991 2019
100
Symbiotic microbes of Saxifraga stellaris ssp. alpigena from the copper creek of Schwarzwand (Austrian Alps) enhance plant tolerance to copper. 61
31029964 2019
101
Fatal case of TAFRO syndrome associated with over-immunosuppression: a case report and review of the literature. 61
31579342 2019
102
Molecular Detection of blaIMP Genes in Metallo-Beta-Lactamase Producing Clinical Gram-Negative Isolates. 61
31414749 2019
103
Sulfonamide-based diffusible signal factor analogs interfere with quorum sensing in Stenotrophomonas maltophilia and Burkholderia cepacia. 61
31469336 2019
104
In Vitro Synergism of Colistin and N-acetylcysteine against Stenotrophomonas maltophilia. 61
31349560 2019
105
Characterization of maltocin S16, a phage tail-like bacteriocin with antibacterial activity against Stenotrophomonas maltophilia and Escherichia coli. 61
31021024 2019
106
Complete Genome Sequence of Stenotrophomonas maltophilia Strain SVIA2, Isolated from Crude Oil-Contaminated Soil in Tabasco, Mexico. 61
31346014 2019
107
Symbiotic cellulolytic bacteria from the gut of the subterranean termite Psammotermes hypostoma Desneux and their role in cellulose digestion. 61
31317283 2019
108
NAD+ -Dependent Enzymatic Route for the Epimerization of Hydroxysteroids. 61
30265441 2019
109
Biofilm Bridges Forming Structural Networks on Patterned Lubricant-Infused Surfaces. 61
31380192 2019
110
ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. 61
30708122 2019
111
[Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016]. 61
31370382 2019
112
Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia. 61
30945726 2019
113
Outbreak of nonfermentative Gram-negative bacteria (Ralstonia pickettii and Stenotrophomonas maltophilia) in a hemodialysis center. 61
30746829 2019
114
Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States. 61
31266860 2019
115
Characterization and properties of the biosurfactant produced by PAH-degrading bacteria isolated from contaminated oily sludge environment. 61
31190304 2019
116
Characterisation of the Major Extracellular Proteases of Stenotrophomonas maltophilia and Their Effects on Pulmonary Antiproteases. 61
31261656 2019
117
A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort Study. 61
30685333 2019
118
Is the Potable Water System an Advantageous Preinfection Niche for Bacteria Colonizing the Cystic Fibrosis Lung? 61
31164466 2019
119
Fatal orbital necrotizing fasciitis secondary to stenotrophomonas maltophilia associated stomatitis. 61
30465891 2019
120
New pyrazinoquinazoline alkaloids Isolated from a culture of Stenotrophomonas maltophilia QB-77. 61
29770716 2019
121
An update on the antimicrobial susceptibility and molecular epidemiology of Stenotrophomonas maltophilia in Bulgaria: a 5-year study (2011-2016). 61
30729875 2019
122
Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. 61
30448331 2019
123
Epidemiological Trends and Resistance Associated with Stenotrophomonas maltophilia Bacteremia: A 10-Year Retrospective Cohort Study in a Tertiary-Care Hospital in Hungary. 61
31159258 2019
124
Toward Antibiofouling PVDF Membranes. 61
31042867 2019
125
Effective biodegradation of chicken feather waste by co-cultivation of keratinase producing strains. 61
31103032 2019
126
Bordetella trematum infection: case report and review of previous cases. 61
31146691 2019
127
Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria. 61
30858212 2019
128
Metagenomic analysis revealed beneficial effects of probiotics in improving the composition and function of the gut microbiota in dogs with diarrhoea. 61
31021333 2019
129
Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience. 61
31058792 2019
130
Concomitant severe influenza and cryptococcal infections: A case report and literature review. 61
31083210 2019
131
Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem. 61
31166553 2019
132
Inactivation of ahpC renders Stenotrophomonas maltophilia resistant to the disinfectant hydrogen peroxide. 61
30467663 2019
133
Characterization of Acquired Antimicrobial Resistance Genes in Environmental Stenotrophomonas maltophilia Isolates from Brazil. 61
30403553 2019
134
Stenotrophomonas maltophilia brain abscesses after implantation of motor cortex stimulator. 61
30889467 2019
135
Antimicrobial and Antibiofilm N-acetyl-L-cysteine Grafted Siloxane Polymers with Potential for Use in Water Systems. 61
31022884 2019
136
Co-Occurrence of Colistin and Meropenem Resistance Determinants in a Stenotrophomonas Strain Isolated from Sewage Water. 61
30864883 2019
137
Isolation and characterization of mercury-resistant bacteria from wastewater sources in Egypt. 61
30633555 2019
138
Occurrence and characterisation of biofilms in drinking water systems of broiler houses. 61
30987581 2019
139
Stenotrophomonas maltophilia AHL-Degrading Strains Isolated from Marine Invertebrate Microbiota Attenuate the Virulence of Pectobacterium carotovorum and Vibrio coralliilyticus. 61
30762152 2019
140
AmpI Functions as an Iron Exporter To Alleviate β-Lactam-Mediated Reactive Oxygen Species Stress in Stenotrophomonas maltophilia. 61
30745379 2019
141
In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015. 61
30471402 2019
142
Functional and Genetic Diversity of Bacteria Associated with the Surfaces of Agronomic Plants. 61
30987359 2019
143
Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center. 61
30097388 2019
144
Complete Genome Sequence of Oxidase-Positive Stenotrophomonas maltophilia Strain SM7059. 61
31023803 2019
145
Novel Stenotrophomonas maltophilia temperate phage DLP4 is capable of lysogenic conversion. 61
30991961 2019
146
In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates 61
30866602 2019
147
Roles of the Two-MnSOD System of Stenotrophomonas maltophilia in the Alleviation of Superoxide Stress. 61
30974814 2019
148
Cystic Fibrosis-Associated Stenotrophomonas maltophilia Strain-Specific Adaptations and Responses to pH. 61
30642989 2019
149
Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens. 61
31013936 2019
150
Contact Lens-Associated Microbial Keratitis in a Tertiary Eye Care Center in Turkey. 61
31045617 2019
151
Carbapenem resistant organisms: A 9-year surveillance and trends at Saint George University Medical Center. 61
30956158 2019
152
Community acquired Stenotrophomonas maltophilia discitis: Diagnosis aided by shotgun metagenomic sequencing. 61
30684744 2019
153
Involvement of the RND efflux pump transporter SmeH in the acquisition of resistance to ceftazidime in Stenotrophomonas maltophilia. 61
30894628 2019
154
Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016). 61
30895213 2019
155
The rpf/DSF signalling system of Stenotrophomonas maltophilia positively regulates biofilm formation, production of virulence-associated factors and β-lactamase induction. 61
31044250 2019
156
Impact of piperacillin/tazobactam on nephrotoxicity in patients with Gram-negative bacteraemia. 61
30415001 2019
157
Stenotrophomonas maltophilia Endocarditis of an Implantable Cardioverter Defibrillator Lead. 61
31065471 2019
158
Polymicrobial Keratitis With Cryptococcus curvatus, Candida parapsilosis, and Stenotrophomonas maltophilia After Penetrating Keratoplasty: A Rare Case Report With Literature Review. 61
29944507 2019
159
Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry. 61
30741162 2019
160
Stenotrophomonas maltophilia - a low-grade pathogen with numerous virulence factors. 61
30422737 2019
161
Bioinert Control of Zwitterionic Poly(ethylene terephtalate) Fibrous Membranes. 61
29925240 2019
162
A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis. 61
30426331 2019
163
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan. 61
30357343 2019
164
Polymerase Chain Reaction Assay Using the Restriction Fragment Length Polymorphism Technique in the Detection of Prosthetic Joint Infections: A Multi-Centered Study. 61
30471785 2019
165
A culture-dependent and metagenomic approach of household drinking water from the source to point of use in a developing country. 61
31194061 2019
166
Munchausen by proxy syndrome mimicking childhood-onset systemic lupus erythematosus. 61
30616452 2019
167
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. 61
30712199 2019
168
Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis. 61
30421302 2019
169
Isolation and identification of marine strains of Stenotrophomona maltophilia with high chitinolytic activity. 61
30627485 2019
170
ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases. 61
30323050 2019
171
California condor microbiomes: Bacterial variety and functional properties in captive-bred individuals. 61
31825977 2019
172
Bacterial composition of biofilms formed on dairy-processing equipment. 61
30896323 2019
173
Volatiles of rhizobacteria Serratia and Stenotrophomonas alter growth and metabolite composition of Arabidopsis thaliana. 61
30030887 2019
174
Species Interaction and Selective Carbon Addition During Antibiotic Exposure Enhances Bacterial Survival. 61
31849882 2019
175
Repressed Beauveria bassiana infections in Delia antiqua due to associated microbiota. 61
29797399 2019
176
Plant growth promoting rhizobacterium Stenotrophomonas maltophilia BJ01 augments endurance against N2 starvation by modulating physiology and biochemical activities of Arachis hypogea. 61
31513643 2019
177
Substantial Contribution of SmeDEF, SmeVWX, SmQnr, and Heat Shock Response to Fluoroquinolone Resistance in Clinical Isolates of Stenotrophomonas maltophilia. 61
31057523 2019
178
Characterization of Phenotypic and Genotypic Diversity of Stenotrophomonas maltophilia Strains Isolated From Selected Hospitals in Iran. 61
31191502 2019
179
Prevalence and Antibiotic Resistance of Stenotrophomonas maltophilia in Respiratory Tract Samples: A 10-Year Epidemiological Snapshot. 61
31453265 2019
180
Phenotypic and Genotypic Identification of Bacteria Isolated From Traditionally Prepared Dry Starters of the Eastern Himalayas. 61
31749787 2019
181
Bioaugmentation of PAH-Contaminated Soils With Novel Specific Degrader Strains Isolated From a Contaminated Industrial Site. Effect of Hydroxypropyl-β-Cyclodextrin as PAH Bioavailability Enhancer. 61
31798552 2019
182
[Performance of MALDI-TOF MS for the identification of gram-negative bacteria grown on eosin methylene blue (EMB) agar: A simple method for improving the effectiveness of identification]. 61
30683034 2019
183
Microbiological and Cellular Evaluation of a Fluorine-Phosphorus-Doped Titanium Alloy, a Novel Antibacterial and Osteostimulatory Biomaterial with Potential Applications in Orthopedic Surgery. 61
30367003 2019
184
Is Meropenem as a Monotherapy Truly Incompetent for Meropenem-Nonsusceptible Bacterial Strains? A Pharmacokinetic/Pharmacodynamic Modeling With Monte Carlo Simulation. 61
31849910 2019
185
Clinical Features, Outcomes, and Risk Factors of Bloodstream Infections due to Stenotrophomonas maltophilia in a Tertiary-Care Hospital of China: A Retrospective Analysis. 61
31886220 2019
186
Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens - The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study. 61
31819544 2019
187
In vitro Evaluation of BACT/ALERT® VIRTUO®, BACT/ALERT 3D®, and BACTEC™ FX Automated Blood Culture Systems for Detection of Microbial Pathogens Using Simulated Human Blood Samples. 61
30837964 2019
188
Moving Beyond the Host: Unraveling the Skin Microbiome of Endangered Costa Rican Amphibians. 61
31572313 2019
189
A Mosquito Bite with Devastating Complications in an Immunocompromised Patient. 61
30792641 2019
190
Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts. 61
31814964 2019
191
Stenotrophomonas maltophilia right-sided endocarditis in an adult patient with uncorrected congenital heart disease. 61
31193537 2019
192
Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients. 61
30240837 2019
193
Stenotrophomonas maltophilia-A Case Series of a Rare Keratitis Affecting Patients With Bandage Contact Lens. 61
29369229 2019
194
Marked deterioration in rheumatoid arthritis associated bronchiectasis following treatment with Rituximab. 61
31360633 2019
195
Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry. 61
30620748 2019
196
Endocarditis caused by Stenotrophomonas maltophilia-A rare presentation of an emerging opportunistic pathogen. 61
31193238 2019
197
STENOTROPHOMONAS MALTOPHILIA ENDOPHTHALMITIS 1 MONTH AFTER INTRAVITREAL AFLIBERCEPT. 61
28358745 2019
198
Predictors of Outcomes in Patients with Prolonged Weaning with Focus on Respiratory Tract Pathogens and Infection. 61
30332675 2019
199
Intranasal immunization with recombinant outer membrane protein A induces protective immune response against Stenotrophomonas maltophilia infection. 61
30934008 2019
200
Metagenomic Analysis Identified Stenotrophomonas maltophilia Pneumonia in an Infant Suffering From Unexplained Very Severe Pneumonia. 61
31608265 2019
201
The etiology of neonatal pneumonia, complicated by bronchopulmonary dysplasia. 61
31381532 2019
202
Multiplex real-time PCR assays to detect Stenotrophomonas maltophilia carrying sul1, sul2, and sul3 genes. 61
30529240 2019
203
Structure-Dependent Inhibition of Stenotrophomonas maltophilia by Polyphenol and Its Impact on Cell Membrane. 61
31798564 2019
204
Isolation, Characterization, and Inactivation of Stenotrophomonas maltophilia From Leafy Green Vegetables and Urban Agriculture Systems. 61
31849874 2019
205
Trimethoprim/Sulfamethoxazole and Moxifloxacin Therapy for a Pediatric Stenotrophomonas Maltophilia Ventriculoperitoneal Shunt Infection. 61
30837817 2019
206
The effects of emerging environmental contaminants on Stenotrophomonas maltophilia isolated from drinking water in planktonic and sessile states. 61
30189551 2018
207
Multidrug-resistant Stenotrophomonas maltophilia: Description of new MLST profiles and resistance and virulence genes using whole-genome sequencing. 61
30036694 2018
208
Correction to: Molecular, biochemical and kinetic analysis of a novel, thermostable lipase (LipSm) from Stenotrophomonas maltophilia Psi‑1, the first member of a new bacterial lipase family (XIX). 61
29942797 2018
209
Molecular, biochemical and kinetic analysis of a novel, thermostable lipase (LipSm) from Stenotrophomonas maltophilia Psi-1, the first member of a new bacterial lipase family (XVIII). 61
29456971 2018
210
Isolation of a feather-degrading strain of bacterium from spider gut and the purification and identification of its three key enzymes. 61
30168098 2018
211
Evaluation of FISH for Blood Cultures under Diagnostic Real-Life Conditions. 61
30719330 2018
212
Retraction Note to: An assessment of transgenomics as a tool for gene discovery in Populus euphratica Oliv. 61
30478705 2018
213
Data on whole genome shotgun sequencing report of clinical S. maltophilia strains from India. 61
30364539 2018
214
Fatal Neutropenic Enterocolitis Caused by Stenotrophomonas maltophilia: A Rare and Underrecognized Entity. 61
30101922 2018
215
Early prosthetic endocarditis caused by Stenotrophomonas maltophilia. 61
30336969 2018
216
Utility of MALDI-TOF mass spectrometry in an outbreak investigation of acute endophthalmitis following intravitreal injection. 61
29605188 2018
217
Polymerase Chain Reaction Assay for Detection of Stenotrophomonas maltophilia in Cheese Samples Based on the smeT Gene. 61
30155670 2018
218
Antimicrobial susceptibility and sessile behaviour of bacteria isolated from a minimally processed vegetables plant. 61
30663892 2018
219
Integrons and insertion sequence common region 1 (ISCR1) of carbapenem-non-susceptible Gram-negative bacilli in fecal specimens from 5000 patients in southern China. 61
29960008 2018
220
Effectiveness of Reprocessing for Flexible Bronchoscopes and Endobronchial Ultrasound Bronchoscopes. 61
29859183 2018
221
Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17). 61
30060117 2018
222
Biogenic selenium nanoparticles synthesized by Stenotrophomonas maltophilia SeITE02 loose antibacterial and antibiofilm efficacy as a result of the progressive alteration of their organic coating layer. 61
29635772 2018
223
[Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients]. 61
30481922 2018
224
Biolog Phenotype Microarray Is a Tool for the Identification of Multidrug Resistance Efflux Pump Inducers. 61
30126958 2018
225
Bacterial Pathogens Differed Between Neutropenic and Non-neutropenic Patients in the Same Hematological Ward: An 8-Year Survey. 61
30423039 2018
226
Rapid detection of four non-fermenting Gram-negative bacteria directly from cystic fibrosis patient's respiratory samples on the BD MAX™ system. 61
30009245 2018
227
Impacts of L1 Promoter Variation and L2 Clavulanate Susceptibility on Ticarcillin-Clavulanate Susceptibility of Stenotrophomonas maltophilia. 61
30150476 2018
228
Adhesion of Stenotrophomonas maltophilia, Delftia acidovorans, and Achromobacter xylosoxidans to Contact Lenses. 61
28953600 2018
229
Stenotrophomonas maltophilia Causing Recurrent Acute Canaliculitis. 61
30418402 2018
230
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression. 61
30124833 2018
231
Bacterial community structure and diversity in the gut of the muga silkworm, Antheraea assamensis (Lepidoptera: Saturniidae), from India. 61
29663550 2018
232
Toward the Detection and Identification of Single Bacteria by Electrochemical Collision Technique. 61
30209941 2018
233
Comparative antibacterial effects of cellulose nanofiber, chitosan nanofiber, chitosan/cellulose combination and chitosan alone against bacterial contamination of Iranian banknotes. 61
29966671 2018
234
[Risk factors and etiological analysis of ventilator-associated pneumonia: three year's cases analysis of intensive care unit in county hospital]. 61
30439311 2018
235
[Surveillance of resistance in the intensive care units using a cumulative antibiogram]. 61
30522419 2018
236
Characterization and Thermal Denaturation Kinetic Analysis of Recombinant l-Amino Acid Ester Hydrolase from Stenotrophomonas maltophilia. 61
30277765 2018
237
Severe hepatic abscess: Conservative treatment of multi-organ infection by Stenotrophomonas maltophilia. A case report. 61
30237880 2018
238
Management of Stenotrophomonas maltophilia Infections in Critically Ill Children. 61
29634621 2018
239
Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study. 61
30219056 2018
240
Intracellular transformation rates of fatty acids are influenced by expression of the fatty acid transporter FadL in Escherichia coli cell membrane. 61
30016739 2018
241
Influence of salts and metal nanoparticles on the activity and thermal stability of a recombinant chitinase from Stenotrophomonas maltophilia N4. 61
29887018 2018
242
LotS/LotR/Clp, a novel signal pathway responding to temperature, modulating protease expression via c-di-GMP mediated manner in Stenotrophomonas maltophilia FF11. 61
30031482 2018
243
Contemporary Threats of Bacterial Infections in Freshwater Fish. 61
30584602 2018
244
Bacterial Infections During Hospital Stay and Their Impact on Mortality After Lung Transplantation: A Single-Center Study. 61
30177110 2018
245
Stenotrophomonas maltophilia: A Rare Case of Osteomyelitis After an Open Distal Tibial Fracture. 61
29748104 2018
246
In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis. 61
30016231 2018
247
In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis. 61
29559421 2018
248
Draft Genome Sequences of Two Cystic Fibrosis Strains of Stenotrophomonas maltophilia, AU30115 and AU32848. 61
30533649 2018
249
ClpA and HtpX Proteases Are Involved in Intrinsic Aminoglycoside Resistance of Stenotrophomonas maltophilia and Are Potential Aminoglycoside Adjuvant Targets. 61
29760139 2018
250
Complete Genome Sequence of Stenotrophomonas maltophilia AB550, an Environmental Solar Radiation- and Multidrug-Resistant Strain Isolated in Western Australia. 61
30533889 2018
251
Disruption of mpl Activates β-Lactamase Production in Stenotrophomonas maltophilia and Pseudomonas aeruginosa Clinical Isolates. 61
29844045 2018
252
The action of chemical and mechanical stresses on single and dual species biofilm removal of drinking water bacteria. 61
29728008 2018
253
Construction of Effective Minimal Active Microbial Consortia for Lignocellulose Degradation. 61
29392382 2018
254
Successful nonsurgical therapy of a diabetic foot osteomyelitis in a patient with peripheral artery disease with almost complete radiological restoration. 61
30103808 2018
255
Microbial Interactions in the Cystic Fibrosis Airway. 61
29769279 2018
256
The preparation and clinical application of diagnostic DNA microarray for the detection of pathogens in intracranial bacterial and fungal infections. 61
30116379 2018
257
Identification of N-acyl homoserine lactone-degrading bacteria isolated from rainbow trout (Oncorhynchus mykiss). 61
29694709 2018
258
Larvicidal efficacy of Adiantobischrysene from Adiantum latifolium against Oryctes rhinoceros through disrupting metamorphosis and impeding microbial mediated digestion. 61
29393564 2018
259
Diffusible signal factor signaling regulates multiple functions in the opportunistic pathogen Stenotrophomonas maltophilia. 61
30097057 2018
260
Taxonogenomics reveal multiple novel genomospecies associated with clinical isolates of Stenotrophomonas maltophilia. 61
30084764 2018
261
Putative Iron Acquisition Systems in Stenotrophomonas maltophilia. 61
30115820 2018
262
Risk factors for death from Stenotrophomonas maltophilia bacteremia. 61
29673561 2018
263
Simulation of a surface spill of different diesel/biodiesel mixtures in an ultisol, using natural attenuation and bioaugmentation/biostimulation. 61
30304219 2018
264
Cefiderocol (S-649266), A new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: Structure activity relationship. 61
29960205 2018
265
Persistent contamination of heater-cooler units for extracorporeal circulation cured by chlorhexidine-alcohol in water tanks. 61
29331660 2018
266
Stenotrophomonas maltophilia isolated from patients exposed to invasive devices in a university hospital in Argentina: molecular typing, susceptibility and detection of potential virulence factors. 61
29799387 2018
267
Treatment of Aspergillus fumigatus infection with posaconazole delayed-release tablets. 61
29941535 2018
268
Microbiota of Palm Oil Mill Wastewater in Malaysia. 61
30112146 2018
269
Screening of microbial communities associated with endive lettuce during postharvest processing on industrial scale. 61
30094360 2018
270
Stenotrophomonas maltophilia. 61
29754971 2018
271
[Analysis on clinical characteristics of 13 extremely severe burn patients complicated with severe inhalation injury in August 2nd Kunshan factory aluminum dust explosion accident]. 61
30060346 2018
272
Identification of immunogenic outer membrane proteins and evaluation of their protective efficacy against Stenotrophomonas maltophilia. 61
30053835 2018
273
Stenotrophomonas maltophilia causing blood stream infection in neonates and infants: a cause for concern. 61
29161992 2018
274
Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis. 61
29790674 2018
275
Resurgence of Global Opportunistic Multidrug-resistant Stenotrophomonas maltophilia. 61
30111925 2018
276
Identification and Characterization of Type IV Pili as the Cellular Receptor of Broad Host Range Stenotrophomonas maltophilia Bacteriophages DLP1 and DLP2. 61
29925793 2018
277
Overexpression of the Efflux Pumps SmeVWX and SmeDEF Is a Major Cause of Resistance to Co-trimoxazole in Stenotrophomonas maltophilia. 61
29610195 2018
278
Degradation of 4-chlorophenol and microbial diversity in soil inoculated with single Pseudomonas sp. CF600 and Stenotrophomonas maltophilia KB2. 61
29573672 2018
279
Retraction for Fouhy et al., "Diffusible Signal Factor-Dependent Cell-Cell Signaling and Virulence in the Nosocomial Pathogen Stenotrophomonas maltophilia". 61
29794246 2018
280
Are animals a source of Stenotrophomonas maltophilia in human infections? Contributions of a nationwide molecular study. 61
29488120 2018
281
Complete Genome Sequence of Ebrios, a Novel T7virus Isolated from the Ebrie Lagoon in Abidjan, Côte d'Ivoire. 61
29930030 2018
282
Stenotrophomonas lactitubi sp. nov. and Stenotrophomonas indicatrix sp. nov., isolated from surfaces with food contact. 61
29638210 2018
283
Survival of antibiotic resistant bacteria following artificial solar radiation of secondary wastewater effluent. 61
29898509 2018
284
Quantification of the Composition Dynamics of a Maize Root-associated Simplified Bacterial Community and Evaluation of Its Biological Control Effect. 61
30123815 2018
285
Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods. 61
30015451 2018
286
The epidemiology, antibiograms and predictors of mortality among critically-ill patients with central line-associated bloodstream infections. 61
28943144 2018
287
Acanthamoeba S13WT relies on its bacterial endosymbiont to backpack human pathogenic bacteria and resist Legionella infection on solid media. 61
29611898 2018
288
Residual moisture and waterborne pathogens inside flexible endoscopes: Evidence from a multisite study of endoscope drying effectiveness. 61
29609854 2018
289
Degradation of petroleum hydrocarbons and treatment of refinery wastewater under saline condition by a halophilic bacterial consortium enriched from marine environment (Red Sea), Jeddah, Saudi Arabia. 61
29872607 2018
290
Listeria monocytogenes strains show large variations in competitive growth in mixed culture biofilms and suspensions with bacteria from food processing environments. 61
29631210 2018
291
Antimicrobial efficacy of a novel povidone iodine contact lens disinfection system. 61
29233457 2018
292
Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016). 61
29410368 2018
293
Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years. 61
29307014 2018
294
Superior Bioinert Capability of Zwitterionic Poly(4-vinylpyridine propylsulfobetaine) Withstanding Clinical Sterilization for Extended Medical Applications. 61
29738230 2018
295
In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014-2015. 61
29338931 2018
296
Characterization of bacterial diversity in contaminated groundwater using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. 61
29054663 2018
297
Detection of blaNDM-1 in Stenotrophomonas maltophilia isolated from Brazilian soil. 61
29768625 2018
298
Overexpression of Stenotrophomonas maltophilia major facilitator superfamily protein MfsA increases resistance to fluoroquinolone antibiotics. 61
29462315 2018
299
Whole genome analysis of six organophosphate-degrading rhizobacteria reveals putative agrochemical degradation enzymes with broad substrate specificity. 61
29502257 2018
300
Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report. 61
29843675 2018
301
Comparative activity of antimicrobials against Pseudomonas aeruginosa, Achromobacter xylosoxidans and Stenotrophomonas maltophilia keratitis isolates. 61
29459431 2018
302
Data on the effect of Pseudomonas stutzeri E25 and Stenotrophomonas maltophilia CR71 culture supernatants on the mycelial growth of Botrytis cinerea. 61
29387737 2018
303
Improved polycyclic aromatic hydrocarbon degradation in a crude oil by individual and a consortium of bacteria. 61
29413920 2018
304
β LACTA test performance for detection of extended-spectrum β-lactamase-producing Gram-negative bacilli directly on bronchial aspirates samples: a validation study. 61
28782646 2018
305
Real-time exhaled breath analysis in patients with cystic fibrosis and controls. 61
29555894 2018
306
Stenotrophomonas maltophilia: A marker of lung disease severity. 61
29314745 2018
307
Biochemical properties of the HtrA homolog from bacterium Stenotrophomonas maltophilia. 61
29155201 2018
308
Selecting Bacterial Antagonists for Cucurbit Downy Mildew and Developing an Effective Application Method. 61
30673494 2018
309
Purification and characterization of Stenotrophomonas maltophilia-derived l-amino acid ester hydrolase for synthesizing dipeptide, isoleucyl-tryptophan. 61
29556427 2018
310
Improved biosynthesis of silver nanoparticles using keratinase from Stenotrophomonas maltophilia R13: reaction optimization, structural characterization, and biomedical activity. 61
29204731 2018
311
Presence of Stenotrophomonas maltophilia exhibiting high genetic similarity to clinical isolates in final effluents of pig farm wastewater treatment plants. 61
29254843 2018
312
High Genetic Diversity among Stenotrophomonas maltophilia Isolates from Single Hospital: Nosocomial Outbreaks or Genotypic Profile Changes during Subcultures. 61
30918454 2018
313
Active-site mutations improved the transglycosylation activity of Stenotrophomonas maltophilia chitinase A. 61
29233759 2018
314
Functional metagenomics reveals a novel carbapenem-hydrolyzing mobile beta-lactamase from Indian river sediments contaminated with antibiotic production waste. 61
29316517 2018
315
Antimicrobial Efficacy of Multipurpose Disinfecting Solutions in the Presence of Contact Lenses and Lens Cases. 61
27598555 2018
316
Complete Genome Sequence of Temperate Stenotrophomonas maltophilia Bacteriophage DLP5. 61
29496826 2018
317
Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections. 61
28964955 2018
318
Bacteria induce autophagy in a human ocular surface cell line. 61
29288646 2018
319
Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia. 61
29408828 2018
320
Reduction of Hexavalent Chromium and Detection of Chromate Reductase (ChrR) in Stenotrophomonas maltophilia. 61
29438314 2018
321
Role of smeU1VWU2X Operon in Alleviation of Oxidative Stresses and Occurrence of Sulfamethoxazole-Trimethoprim-Resistant Mutants in Stenotrophomonas maltophilia. 61
29203487 2018
322
Surveillance of antimicrobial susceptibility patterns among Stenotrophomonas maltophilia isolated in China during the 10-year period of 2005-2014. 61
28949279 2018
323
Synthesis of Chitin Oligosaccharides Using Dried Stenotrophomonas maltophilia Cells Containing a Transglycosylation Reaction-Catalyzing β-N-Acetylhexosaminidase as a Whole-Cell Catalyst. 61
28840460 2018
324
Bioremediation of PCB-contaminated shallow river sediments: The efficacy of biodegradation using individual bacterial strains and their consortia. 61
29141235 2018
325
Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy. 61
29310479 2018
326
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016. 61
29158270 2018
327
[Successful treatment of a necrotizing, multi-resistant bacterial pyoderma in a python with cold plasma therapy]. 61
29536463 2018
328
Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy. 61
29138886 2018
329
[Clinical characteristics of burn patients infected with Stenotrophomonas maltophilia and antibiotic resistance of the strains]. 61
29973024 2018
330
Antimicrobial Resistance in Stenotrophomonas spp. 61
29350131 2018
331
An antibiotic stewardship exercise in the ICU: building a treatment algorithm for the management of ventilator-associated pneumonia based on local epidemiology and the 2016 Infectious Diseases Society of America/American Thoracic Society guidelines. 61
29317840 2018
332
Defining Multidrug Resistance of Gram-Negative Bacteria in the Dutch-German Border Region-Impact of National Guidelines. 61
29373498 2018
333
Potential of high-dose cefepime/tazobactam against multiresistant Gram-negative pathogens. 61
29059308 2018
334
Identification of a Broad-Spectrum Peptidoglycan Hydrolase Associated with the Particle of Xanthomonas oryzae Phage Xop411. 61
29969787 2018
335
Influence of Different Bacteria Strains Isolated from Septic Children on Release and Degradation of Extracellular Traps by Neutrophils from Healthy Adults. 61
30051317 2018
336
Transcriptomic, Functional, and Network Analyses Reveal Novel Genes Involved in the Interaction Between Caenorhabditis elegans and Stenotrophomonas maltophilia. 61
30177956 2018
337
Analysis of Phylogenetic Variation of Stenotrophomonas maltophilia Reveals Human-Specific Branches. 61
29755435 2018
338
Quorum Sensing Signaling and Quenching in the Multidrug-Resistant Pathogen Stenotrophomonas maltophilia. 61
29740543 2018
339
Anti-biofilm and Anti-Virulence Efficacy of Celastrol Against Stenotrophomonas maltophilia. 61
29725253 2018
340
Frequency and Genetic Determinants of Tigecycline Resistance in Clinically Isolated Stenotrophomonas maltophilia in Beijing, China. 61
29632524 2018
341
New bacterial growth in bronchial secretions after bronchoscopic valve implantation. 61
29445273 2018
342
Tracking the spread routes of opportunistic premise plumbing pathogens in a haematology unit with water points-of-use protected by antimicrobial filters. 61
28760634 2018
343
[Uncommon non-fermenting Gram-negative rods as pathogens of lower respiratory tract infection]. 61
29291642 2018
344
SuperPolymyxin™ Medium for the Screening of Colistin-Resistant Gram-Negative Bacteria in Stool Samples. 61
30519224 2018
345
[Polyresistent microflora in the structure of microorganisms divided from blood of patients of the general hospital.] 61
30735325 2018
346
Acceleration of the formation of biofilms on contact lens surfaces in the presence of neutrophil-derived cellular debris is conserved across multiple genera. 61
29422767 2018
347
Temperature-Dependent Effects of Cutaneous Bacteria on a Frog's Tolerance of Fungal Infection. 61
29563909 2018
348
Silver-pig skin nanocomposites and mesenchymal stem cells: suitable antibiofilm cellular dressings for wound healing. 61
29321021 2018
349
Hospitalized Pets as a Source of Carbapenem-Resistance. 61
30574124 2018
350
Heterogeneous Colistin-Resistance Phenotypes Coexisting in Stenotrophomonas maltophilia Isolates Influence Colistin Susceptibility Testing. 61
30524420 2018
351
Iron and Virulence in Stenotrophomonas Maltophilia: All We Know So Far. 61
30483485 2018
352
The Ax21 protein influences virulence and biofilm formation in Stenotrophomonas maltophilia. 61
28965241 2018
353
Survival and growth of Stenotrophomonas maltophilia in free-living amoebae (FLA) and bacterial virulence properties. 61
29401523 2018
354
Stenotrophomonas maltophilia Meningitis in a Term Healthy Neonate: A Case Report and Literature Review. 61
30009072 2018
355
Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients. 61
29413513 2018
356
Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms. 61
30464547 2018
357
Physical-Chemical Properties of Biogenic Selenium Nanostructures Produced by Stenotrophomonas maltophilia SeITE02 and Ochrobactrum sp. MPV1. 61
30619230 2018
358
Microbial spectrum and drug-resistance profile of isolates causing bloodstream infections in febrile cancer patients at a referral hospital in Addis Ababa, Ethiopia. 61
30271184 2018
359
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. 61
29230684 2018
360
Interactions of Aspergillus fumigatus and Stenotrophomonas maltophilia in an in vitro Mixed Biofilm Model: Does the Strain Matter? 61
30542331 2018
361
In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm. 61
30273348 2018
362
Antibacterial and Antibiofilm Activities of Nonpolar Extracts of Allium stipitatum Regel. against Multidrug Resistant Bacteria. 61
30105271 2018
363
Stenotrophomonas maltophilia Necrotizing Soft Tissue Infection in an Immunocompromised Patient. 61
29805813 2018
364
[Italian Cystic Fibrosis Registry. Report 2011-2014]. 61
29506377 2018
365
Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival. 61
30024969 2018
366
Electrochemically Synthesized Silver Nanoparticles Are Active Against Planktonic and Biofilm Cells of Pseudomonas aeruginosa and Other Cystic Fibrosis-Associated Bacterial Pathogens. 61
30026732 2018
367
Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates. 61
29319523 2017
368
Stenotrophomonas maltophilia Serine Protease StmPr1 Induces Matrilysis, Anoikis, and Protease-Activated Receptor 2 Activation in Human Lung Epithelial Cells. 61
28893914 2017
369
The effect of interactions between a bacterial strain isolated from drinking water and a pathogen surrogate on biofilms formation diverged under static vs flow conditions. 61
28960713 2017
370
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients. 61
29254478 2017
371
Colistin resistance among blood culture isolates at a tertiary care centre in Hungary. 61
28838854 2017
372
Biocompatible Copper Oxide Nanoparticle Composites from Cellulose and Chitosan: Facile Synthesis, Unique Structure, and Antimicrobial Activity. 61
29152974 2017
373
Stenotrophomonas maltophilia pericarditis. 61
29256885 2017
374
Stenotrophomonas maltophilia: an emerging multidrug-resistant opportunistic pathogen in the immunocompromised host. 61
29269358 2017
375
Stenotrophomonas maltophilia isolated from prostatic fluid as an infertility factor in a male dog. 61
28261845 2017
376
Stenotrophomonas maltophilia CSF infection in infants after neurosurgery. 61
29240495 2017
377
Diversity of free-living amoebae in soils and their associated human opportunistic bacteria. 61
28988383 2017
378
Antimicrobial resistance and genetic diversity in ceftazidime non-susceptible bacterial pathogens from ready-to-eat street foods in three Taiwanese cities. 61
29138446 2017
379
Using phenotype microarrays in the assessment of the antibiotic susceptibility profile of bacteria isolated from wastewater in on-site treatment facilities. 61
28451946 2017
380
Establishing Genotype-to-Phenotype Relationships in Bacteria Causing Hospital-Acquired Pneumonia: A Prelude to the Application of Clinical Metagenomics. 61
29186015 2017
381
Periplasmic form of dipeptidyl aminopeptidase IV from Pseudoxanthomonas mexicana WO24: purification, kinetic characterization, crystallization and X-ray crystallographic analysis. 61
29095153 2017
382
[A multicenter, retrospective study of pathogenic bacteria distribution and drug resistance in febrile neutropenic patients with hematological diseases in Shanghai]. 61
29224317 2017
383
Genome-wide analysis shows that RNase G plays a global role in the stability of mRNAs in Stenotrophomonas maltophilia. 61
29167539 2017
384
Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates. 61
28876489 2017
385
Co-infection of Pseudomonas aeruginosa and Stenotrophomonas maltophilia in hospitalised pneumonia patients has a synergic and significant impact on clinical outcomes. 61
28669016 2017
386
Public health and healthcare-associated risk of electric, warm-water bidet toilets. 61
28756169 2017
387
Fibrous Catalyst-Enhanced Acanthamoeba Disinfection by Hydrogen Peroxide. 61
28902008 2017
388
Stenotrophomonas maltophilia: A rare cause of peritonitis in capd patients. 61
28578862 2017
389
[Incidence of blood stream infections of 1265 patients with hematopoietic stem cell transplantation and analysis of pathogenic bacteria]. 61
29224313 2017
390
Stenotrophomonas maltophilia produces an EntC-dependent catecholate siderophore that is distinct from enterobactin. 61
28984234 2017
391
Paediatric infectious keratitis: a case series of 107 children presenting to a tertiary referral centre. 61
28298316 2017
392
Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis. 61
29133644 2017
393
Risk factors for hospital acquisition of trimethoprim-sulfamethoxazole resistant Stenotrophomonas maltophilia in adults: A matched case-control study. 61
28688829 2017
394
The presence of biofilm forming microorganisms on hydrotherapy equipment and facilities. 61
29215356 2017
395
Enteric bacteria of food ice and their survival in alcoholic beverages and soft drinks. 61
28648289 2017
396
Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis. 61
28815999 2017
397
The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease. 61
28374901 2017
398
Stenotrophomonas maltophilia: A Gram-Negative Bacterium Useful for Transformations of Flavanone and Chalcone. 61
29077064 2017
399
Membrane vesicle secretion and prophage induction in multidrug-resistant Stenotrophomonas maltophilia in response to ciprofloxacin stress. 61
28488744 2017
400
The Difficulty in Administering Appropriate Antimicrobial Therapy for Stenotrophomonas maltophilia Bacteremia. 61
28924133 2017
401
Reply to "The Difficulty in Administering Appropriate Antimicrobial Therapy for Stenotrophomonas maltophilia Bacteremia". 61
28924135 2017
402
Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam. 61
28784669 2017
403
Distribution and characterization of Stenotrophomonas maltophilia isolates from environmental and clinical samples in Thailand. 61
28602707 2017
404
Stenotrophomonas maltophilia: From trivial to grievous. 61
29405136 2017
405
Outbreak Of Extensively Drug Resistant Stenotrophomonas Maltophilia In Burn Unit. 61
29331006 2017
406
Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation. 61
28938875 2017
407
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study). 61
28630181 2017
408
Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae. 61
28652234 2017
409
Background Nutrients Affect the Biotransformation of Tetracycline by Stenotrophomonas maltophilia as Revealed by Genomics and Proteomics. 61
28837770 2017
410
Moxifloxacin reduces Stenotrophomonas maltophilia adhesion to mouse intestinal tract in vitro. 61
29084698 2017
411
[Analysis of characteristics of bacteria in respiratory tract infection in 2013-2016 in Heibei 3A hospital: a single-center report of 7 497 patients]. 61
28936955 2017
412
Activity of innate antimicrobial peptides and ivacaftor against clinical cystic fibrosis respiratory pathogens. 61
28666755 2017
413
Stenotrophomonas bentonitica sp. nov., isolated from bentonite formations. 61
28820086 2017
414
A Genoproteomic Approach to Detect Peptide Markers of Bacterial Respiratory Pathogens. 61
28588123 2017
415
The effect of dietary bacterial organic selenium on growth performance, antioxidant capacity, and Selenoproteins gene expression in broiler chickens. 61
28821244 2017
416
Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles. 61
28520867 2017
417
An assessment on the role of endophytic microbes in the therapeutic potential of Fagonia indica. 61
28764775 2017
418
Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico. 61
28771141 2017
419
Stenotrophomonas maltophilia is highly prevalent among houseflies (Musca domestica). 61
28771133 2017
420
Distribution of Class I Integron and smqnr Resistance Gene Among Stenotrophomonas maltophilia Isolated from Clinical Samples in Iran. 61
28706609 2017
421
Impacts of Penicillin Binding Protein 2 Inactivation on β-Lactamase Expression and Muropeptide Profile in Stenotrophomonas maltophilia. 61
28861525 2017
422
Biocidal efficacy of multipurpose solutions against Gram-negative organisms associated with corneal infiltrative events. 61
28194876 2017
423
Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome. 61
28701159 2017
424
Stenotrophomonas maltophilia in a university hospital of traditional Chinese medicine: molecular epidemiology and antimicrobial resistance. 61
28502480 2017
425
Molecular epidemiology and characteristics of 16 cases with Stenotrophomonas maltophilia bacteraemia in pediatric Intensive Care Units. 61
28569336 2017
426
BsmR degrades c-di-GMP to modulate biofilm formation of nosocomial pathogen Stenotrophomonas maltophilia. 61
28680041 2017
427
[Distribution and drug resistance of pathogens at hematology department of Jiangsu Province from 2014 to 2015: results from a multicenter, retrospective study]. 61
28810329 2017
428
Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis. 61
28750627 2017
429
In Vitro and In Vivo Control of Secondary Bacterial Infection Caused by Leishmania major. 61
28703780 2017
430
In vitro antibacterial activity of MGDG-palmitoyl from Oscillatoria acuminata NTAPC05 against extended-spectrum β-lactamase producers. 61
28377637 2017
431
A chromatographic approach to distinguish Gram-positive from Gram-negative bacteria using exogenous volatile organic compound metabolites. 61
28438317 2017
432
Hemodialyzer Reuse and Gram-Negative Bloodstream Infections. 61
27940061 2017
433
Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. 61
28599639 2017
434
Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience. 61
28205160 2017
435
Stenotrophomonas maltophilia healthcare-associated infections: identification of two main pathogenic genetic backgrounds. 61
28318778 2017
436
Biodegradation of α-endosulfan via hydrolysis pathway by Stenotrophomonas maltophilia OG2. 61
28567625 2017
437
MALDI-TOF mass spectrometry: An emerging tool for unequivocal identification of non-fermenting Gram-negative bacilli. 61
28948958 2017
438
Inhibitory Activity and Chemical Characterization of Daucus carota subsp. maximus Essential Oils. 61
28171692 2017
439
Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients. 61
28257816 2017
440
Retraction for McCarthy et al., "The Ax21 Protein Is a Cell-Cell Signal That Regulates Virulence in the Nosocomial Pathogen Stenotrophomonas maltophilia". 61
28442539 2017
441
Vitamin K3 Induces the Expression of the Stenotrophomonas maltophilia SmeVWX Multidrug Efflux Pump. 61
28223380 2017
442
Overexpression of SmeDEF Efflux Pump Decreases Aminoglycoside Resistance in Stenotrophomonas maltophilia. 61
28193669 2017
443
In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria. 61
28158732 2017
444
Colonization pressure as a risk factor of ICU-acquired multidrug resistant bacteria: a prospective observational study. 61
28000030 2017
445
Unusual case of rapid growing intraabdominal abscess caused by Stenotrophomonas maltophilia after laparoscopic appendectomy due to perforated appendicitis: A case report. 61
28514306 2017
446
Emergence of Stenotrophomonas maltophilia nosocomial isolates in a Saudi children's hospital. Risk factors and clinical characteristics. 61
28439603 2017
447
[Analysis of the spectrum and resistance of pathogen causing sepsis in patients with severe acute pancreatitis]. 61
28464580 2017
448
Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond. 61
28264910 2017
449
Comparison of Biochemical Properties of the Original and Newly Identified Oleate Hydratases from Stenotrophomonas maltophilia. 61
28235876 2017
450
Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia. 61
28284526 2017
451
Antimicrobial Efficacy of Contact Lens Care Solutions Against Neutrophil-Enhanced Bacterial Biofilms. 61
28473944 2017
452
Yeasts Harbored by Vespine Wasps in the Pacific Northwest. 61
28169397 2017
453
Correlation between circuital current, Cu(II) reduction and cellular electron transfer in EAB isolated from Cu(II)-reduced biocathodes of microbial fuel cells. 61
27835761 2017
454
Copper-tolerant rhizosphere bacteria-characterization and assessment of plant growth promoting factors. 61
28251535 2017
455
Determinants of Antibacterial Spectrum and Resistance Potential of the Elongation Factor G Inhibitor Argyrin B in Key Gram-Negative Pathogens. 61
28096160 2017
456
In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital. 61
29912484 2017
457
In Vitro Activity of Ceftolozane-Tazobactam against Multidrug-Resistant Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis. 61
28096165 2017
458
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. 61
28440853 2017
459
Jacquet erosive diaper dermatitis with Stenotrophomonas maltophilia colonization. 61
28166618 2017
460
A Fresh Shine onCystic Fibrosis Inhalation Therapy: Antimicrobial Synergy of Polymyxin B in Combination with Silver Nanoparticles. 61
29384621 2017
461
Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia infections. 61
28367030 2017
462
Antibiotic susceptibility pattern of Burkholderia cepacia complex and Stenotrophomonas maltophilia: A 5-year analysis. 61
28681835 2017
463
Biotreatment of Petrochemical Wastewater: A Case Study from Northern Tunisia. 61
27094680 2017
464
Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076. 61
28287494 2017
465
[ANTIMICROBIAL AND ANTIFUNGAL ACTIVITY OF LICHENS PREVALENT IN BELARUS]. 61
30695538 2017
466
Simplified and representative bacterial community of maize roots. 61
28275097 2017
467
[THE IDENTIFICATION OF STENOTPHOMONAS MALTOPHILIA USING THE TECHNIQUES OF DIRECT SEQUENATION 16S P RNA AND MALDI-TOF MASS-SPECTROMETRY]. 61
30620529 2017
468
Genetic and biochemical characterization of rhizobacterial strains and their potential use in combination with chelants for assisted phytoremediation. 61
27822692 2017
469
A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity against Stenotrophomonas maltophilia. 61
28894400 2017
470
Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia. 61
27294684 2017
471
Organoselenium Polymer Inhibits Biofilm Formation in Polypropylene Contact Lens Case Material. 61
26974534 2017
472
Nosocomial Infections with IMP-19-Producing Pseudomonas aeruginosa Linked to Contaminated Sinks, France. 61
28098548 2017
473
Fluorescent probe based subcellular distribution of Cu(II) ions in living electrotrophs isolated from Cu(II)-reduced biocathodes of microbial fuel cells. 61
27907871 2017
474
Metagenome-Assembled Draft Genome Sequence of a Novel Microbial Stenotrophomonas maltophilia Strain Isolated from Caenorhabditisremanei Tissue. 61
28209833 2017
475
Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints. 61
27881616 2017
476
Genome Shuffling of Stenotrophomonas maltophilia OK-5 for Improving the Degradation of Explosive RDX (Hexahydro-1,3,5-trinitro-1,3,5-triazine). 61
28004139 2017
477
Selenite biotransformation and detoxification by Stenotrophomonas maltophilia SeITE02: Novel clues on the route to bacterial biogenesis of selenium nanoparticles. 61
26952084 2017
478
Risk of infection transmission in curvilinear array echoendoscopes: results of a prospective reprocessing and culture registry. 61
27478029 2017
479
Bacterial competition and quorum-sensing signalling shape the eco-evolutionary outcomes of model in vitro phage therapy. 61
28127392 2017
480
Potency and selectivity indices of acetone leaf extracts of nine selected South African trees against six opportunistic Enterobacteriaceae isolates from commercial chicken eggs. 61
28148263 2017
481
Polysorbate 80 and polymyxin B inhibit Stenotrophomonas maltophilia biofilm. 61
27923523 2017
482
Physiology and bioprocess of single cell of Stenotrophomonas maltophilia in bioremediation of co-existed benzo[a]pyrene and copper. 61
27607928 2017
483
Relationship of the CreBC two-component regulatory system and inner membrane protein CreD with swimming motility in Stenotrophomonas maltophilia. 61
28437463 2017
484
Evaluation of a Stenotrophomonas maltophilia bacteremia cluster in hematopoietic stem cell transplantation recipients using whole genome sequencing. 61
29158893 2017
485
Evolutionary Genetic Analysis Uncovers Multiple Species with Distinct Habitat Preferences and Antibiotic Resistance Phenotypes in the Stenotrophomonas maltophilia Complex. 61
28861062 2017
486
Biodegradation of polycyclic aromatic hydrocarbons by an acidophilic Stenotrophomonas maltophilia strain AJH1 isolated from a mineral mining site in Saudi Arabia. 61
27848015 2017
487
Global and local selection acting on the pathogen Stenotrophomonas maltophilia in the human lung. 61
28102223 2017
488
Consumption of edible ice contaminated with Acinetobacter, Pseudomonas, and Stenotrophomonas is a risk factor for fecal colonization with extended-spectrum β-lactamase-producing Escherichia coli in Vietnam. 61
29040083 2017
489
Emergence of Carbapenem Resistant Non-Fermenting Gram-Negative Bacilli Isolated in an ICU of a Tertiary Care Hospital. 61
28273965 2017
490
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection. 61
28674688 2017
491
Differential Microbial Diversity in Drosophila melanogaster: Are Fruit Flies Potential Vectors of Opportunistic Pathogens? 61
29234354 2017
492
Coexistence of free-living amoebae and bacteria in selected South African hospital water distribution systems. 61
27730363 2017
493
The PGPR Stenotrophomonas maltophilia SBP-9 Augments Resistance against Biotic and Abiotic Stress in Wheat Plants. 61
29062306 2017
494
Double-Face Meets the Bacterial World: The Opportunistic Pathogen Stenotrophomonas maltophilia. 61
29170656 2017
495
The isolation and characterization of Stenotrophomonas maltophilia T4-like bacteriophage DLP6. 61
28291834 2017
496
Editorial: A Multidisciplinary Look at Stenotrophomonas maltophilia: An Emerging Multi-Drug-Resistant Global Opportunistic Pathogen. 61
28912755 2017
497
Stenotrophomonas maltophilia: An Emerging Pathogen in Paediatric Population. 61
28273966 2017
498
Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series. 61
28090041 2017
499
Rapidly progressive hemorrhagic pneumonia caused by Stenotrophomonas maltophilia occurring early after bone marrow transplantation in a patient with myelodysplastic syndrome. 61
28484160 2017
500
Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients. 61
27346471 2017
501
Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates. 61
27326758 2017
502
Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy. 61
29250041 2017
503
Intraabdominal abscess caused by Stenotrophomonas maltophilia: A case report. 61
29096346 2017
504
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study. 61
28894437 2017
505
Changes in fatty acid composition of Stenotrophomonas maltophilia KB2 during co-metabolic degradation of monochlorophenols. 61
27757793 2016
506
Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital. 61
27007167 2016
507
Current Situation of Antimicrobial Resistance and Genetic Differences in Stenotrophomonas maltophilia Complex Isolates by Multilocus Variable Number of Tandem Repeat Analysis. 61
28032486 2016
508
Gene flow, recombination, and positive selection in Stenotrophomonas maltophilia: mechanisms underlying the diversity of the widespread opportunistic pathogen. 61
27696900 2016
509
Impact of untreated urban waste on the prevalence and antibiotic resistance profiles of human opportunistic pathogens in agricultural soils from Burkina Faso. 61
27696161 2016
510
Improved method for effective screening of ACC (1-aminocyclopropane-1-carboxylate) deaminase producing microorganisms. 61
27769905 2016
511
In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan. 61
26364729 2016
512
Clinical outcomes using minocycline for Stenotrophomonas maltophilia infections. 61
27516472 2016
513
Ventilator-associated pneumonia and the importance of education of ICU nurses on prevention - Preliminary results. 61
28180003 2016
514
Biotransformation of tetracycline by a novel bacterial strain Stenotrophomonas maltophilia DT1. 61
27420384 2016
515
Stenotrophomonas maltophilia outer membrane vesicles elicit a potent inflammatory response in vitro and in vivo. 61
27756813 2016
516
Emerging Trends of Bloodstream Infections: A Six-Year Study at a Paediatric Tertiary Care Hospital in Kabul. 61
27981921 2016
517
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts. 61
27319803 2016
518
Computed Tomography Findings of Community-Acquired Stenotrophomonas Maltophilia Pneumonia in an Immunocompetent Patient: A Case Report. 61
27833412 2016
519
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy. 61
27572416 2016
520
Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric Patients. 61
27994915 2016
521
Rhizobacterial characterization for quality control of eucalyptus biogrowth promoter products. 61
27528088 2016
522
The outer membrane proteins of Stenotrophomonas maltophilia are potential vaccine candidates for channel catfish (Ictalurus punctatus). 61
27574827 2016
523
Major facilitator superfamily MfsA contributes to multidrug resistance in emerging nosocomial pathogen Stenotrophomonas maltophilia. 61
27334664 2016
524
Determination of crystal structures of proteins of unknown identity using a marathon molecular replacement procedure: structure of Stenotrophomonas maltophilia phosphate-binding protein. 61
27710929 2016
525
[Accurate diagnosis of Pseudomonas luteola in routine microbiology laboratory: on the occasion of two isolates]. 61
28124968 2016
526
Stenotrophomonas maltophilia ventilator-associated pneumonia. A retrospective matched case-control study. 61
27207483 2016
527
Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient. 61
27551008 2016
528
Comparative effects of wild type Stenotrophomonas maltophilia and its indole acetic acid-deficient mutants on wheat. 61
27263526 2016
529
Draft Genome Sequence of Stenotrophomonas maltophilia SBo1 Isolated from Bactrocera oleae. 61
27660769 2016
530
A single-center, six-year evaluation of the role of pulsed-field gel electrophoresis in suspected burn center outbreaks. 61
27180602 2016
531
New insight into microbial diversity and functions in traditional Vietnamese alcoholic fermentation. 61
27236224 2016
532
Infective endocarditis caused by Stenotrophomonas maltophilia: A report of two cases and review of literature. 61
27751311 2016
533
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections. 61
27270571 2016
534
[A Case of Bacteremia Urinary Tract Infection Caused by Stenotrophomonas maltophilia in an 8-month-old Boy]. 61
30212051 2016
535
Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF). 61
27050794 2016
536
In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections. 61
27297475 2016
537
Isolation of Stenotrophomonas maltophilia in asymptomatic lung transplant recipients: effects of treatment on eradication and outcome. 61
27219076 2016
538
Effects of Selected Herbicides on Growth and Nitrogen Fixing Activity of Stenotrophomonas maltophilia (Sb16). 61
29334074 2016
539
Stenotrophomonas maltophilia OleC-Catalyzed ATP-Dependent Formation of Long-Chain Z-Olefins from 2-Alkyl-3-hydroxyalkanoic Acids. 61
27238740 2016
540
Draft Genome Sequences of Stenotrophomonas maltophilia Strains Sm32COP, Sm41DVV, Sm46PAILV, SmF3, SmF22, SmSOFb1, and SmCVFa1, Isolated from Different Manures in France. 61
27540065 2016
541
The 1.1 Å resolution structure of a periplasmic phosphate-binding protein from Stenotrophomonas maltophilia: a crystallization contaminant identified by molecular replacement using the entire Protein Data Bank. 61
27487824 2016
542
Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014). 61
27291285 2016
543
Prevalence of Multidrug-Resistant Bacteria on Fresh Vegetables Collected from Farmers' Markets in Connecticut. 61
27497135 2016
544
Differentiation of pulmonary bacterial pathogens in cystic fibrosis by volatile metabolites emitted by their in vitro cultures: Pseudomonas aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia and the Burkholderia cepacia complex. 61
27506232 2016
545
Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia. 61
27495046 2016
546
Microbial Ecosystem Analysis in Root Canal Infections Refractory to Endodontic Treatment. 61
27377440 2016
547
Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013). 61
27112832 2016
548
Outbreak of pulmonary Pseudomonas aeruginosa and Stenotrophomonas maltophilia infections related to contaminated bronchoscope suction valves, Lyon, France, 2014. 61
27458712 2016
549
Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates. 61
27139464 2016
550
Removal of cadmium by bioflocculant produced by Stenotrophomonas maltophilia using phenol-containing wastewater. 61
27108374 2016
551
Effects of Fluoroquinolones and Azithromycin on Biofilm Formation of Stenotrophomonas maltophilia. 61
27405358 2016
552
Practical toolkit for monitoring endoscope reprocessing effectiveness: Identification of viable bacteria on gastroscopes, colonoscopes, and bronchoscopes. 61
26952038 2016
553
Isolation of bacterial strains able to metabolize lignin and lignin-related compounds. 61
27125750 2016
554
ICU Pathogens: A Continuous Challenge. 61
27504548 2016
555
Pine Wilt Disease and Possible Causes of Its Incidence in Russia. 61
30251788 2016
556
Antibacterial Activity of Blue Light against Nosocomial Wound Pathogens Growing Planktonically and as Mature Biofilms. 61
27129967 2016
557
Bacterial and fungal contamination risks in human oocyte and embryo cryopreservation: open versus closed vitrification systems. 61
27025548 2016
558
Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms. 61
27183359 2016
559
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression. 61
27242375 2016
560
Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. 61
27415821 2016
561
Evaluation of the effectiveness of manual and automated dialyzers reprocessing after multiple reuses. 61
26897699 2016
562
Improved catalytic efficiency, thermophilicity, anti-salt and detergent tolerance of keratinase KerSMD by partially truncation of PPC domain. 61
27298079 2016
563
Production, characterization, gene cloning, and nematocidal activity of the extracellular protease from Stenotrophomonas maltophilia N4. 61
26896861 2016
564
Evaluation of antibacterial activity of Stenotrophomonas maltophilia against Ralstonia solanacearum under different application conditions. 61
26876282 2016
565
Emergence of fluoroquinolone-resistant Stenotrophomonas maltophilia in blood isolates causing bacteremia: molecular epidemiology and microbiologic characteristics. 61
27117514 2016
566
Bacteriophages or bacteriovores - that is the question: variations on the theme of eating Stenotrophomonas maltophilia. 61
26971712 2016
567
Proteomic analysis of outer membrane proteins and vesicles of a clinical isolate and a collection strain of Stenotrophomonas maltophilia. 61
27185551 2016
568
Characterization of a salt-activated protease with temperature-dependent secretion in Stenotrophomonas maltophilia FF11 isolated from frozen Antarctic krill. 61
27001262 2016
569
Feather degradation potential of Stenotrophomonas maltophilia KB13 and feather protein hydrolysate (FPH) mediated reduction of hexavalent chromium. 61
28330112 2016
570
Drug Susceptibility Assessment in Stenotrophomonas Maltophilia Strains Isolated From the Blood of Organ Transplantation Recipients in a Warsaw Teaching Hospital During 2011 to 2014. 61
27496417 2016
571
Cloning and characterization of a novel lipase from Stenotrophomonas maltophilia GS11: The first member of a new bacterial lipase family XVI. 61
27117245 2016
572
Relationship of Sulfamethoxazole Therapeutic Drug Monitoring to Clinical Efficacy and Toxicity: A Retrospective Cohort Study. 61
26836809 2016
573
Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes. 61
27303030 2016
574
A Systemic Lupus Erythematosus Patient With Febrile Neutropenia Developing After Intraocular Administration of Bevacizumab. 61
29900958 2016
575
Essential Oil from Origanum vulgare Completely Inhibits the Growth of Multidrug-Resistant Cystic Fibrosis Pathogens. 61
27534136 2016
576
Clinical Characteristics of Stenotrophomonas maltophilia Keratitis. 61
27100655 2016
577
Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study. 61
25081988 2016
578
Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus. 61
26929093 2016
579
Inactivation of Lytic Transglycosylases Increases Susceptibility to Aminoglycosides and Macrolides by Altering the Outer Membrane Permeability of Stenotrophomonas maltophilia. 61
26976867 2016
580
Effects of Endobacterium (Stenotrophomonas maltophilia) on Pathogenesis-Related Gene Expression of Pine Wood Nematode (Bursaphelenchus xylophilus) and Pine Wilt Disease. 61
27231904 2016
581
Draft Genome Sequence of Stenotrophomonas maltophilia CBF10-1, an Organophosphate-Degrading Bacterium Isolated from Ranch Soil in Fairchilds, Texas. 61
27174285 2016
582
Occurrence of Stenotrophomonas maltophilia in agricultural soils and antibiotic resistance properties. 61
26774914 2016
583
Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia. 61
26832758 2016
584
[Progress on the functions of extracellular proteases from Stenotrophomonas maltophilia - A review]. 61
29727134 2016
585
Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria. 61
26953203 2016
586
Isolation and identification of biocellulose-producing bacterial strains from Malaysian acidic fruits. 61
27002476 2016
587
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015] 61
29920041 2016
588
Concomitant presence of Aspergillus fumigatus and Stenotrophomonas maltophilia in the respiratory tract: a new risk for patients with liver disease? 61
26872817 2016
589
An investigation of the bactericidal activity of chlorhexidine digluconateagainst multidrug-resistant hospital isolates. 61
27513272 2016
590
Pseudo-outbreaks of Stenotrophomonas maltophilia on an intensive care unit in England. 61
26876747 2016
591
Intra- and Interspecies Effects of Outer Membrane Vesicles from Stenotrophomonas maltophilia on β-Lactam Resistance. 61
26787686 2016
592
Systematic Mutational Analysis of Histidine Kinase Genes in the Nosocomial Pathogen Stenotrophomonas maltophilia Identifies BfmAK System Control of Biofilm Development. 61
26873318 2016
593
Interim Recommendations for the Reporting of Extensively Drug Resistant and Pan Drug Resistant Isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia. 61
29770011 2016
594
In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides. 61
26815434 2016
595
Characteristics of superinfections during treatment with tigecycline. 61
27077933 2016
596
Diagnosis, Treatment, and Outcome of Stenotrophomonas maltophilia Discitis and Cervical Osteomyelitis: A Case Report and Review of the Literature. 61
29252617 2016
597
Assessment of biofilm formation of E. meningoseptica, D. acidovorans, and S. maltophilia in lens cases and their growth on recovery media. 61
26383012 2016
598
Pulmonary exacerbation due to colistin-resistant Stenotrophomonas maltophilia in a Bulgarian cystic fibrosis patient. 61
27552791 2016
599
In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study. 61
27120170 2016
600
Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. 61
26801080 2016
601
Metabolic biotransformation of copper-benzo[a]pyrene combined pollutant on the cellular interface of Stenotrophomonas maltophilia. 61
26771922 2016
602
Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens. 61
27358626 2016
603
The optimization of fermentation conditions and enzyme properties of Stenotrophomonas maltophilia for protease production. 61
25656812 2016
604
Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement. 61
26627340 2016
605
Stenotrophomonas tumulicola sp. nov., a major contaminant of the stone chamber interior in the Takamatsuzuka Tumulus. 61
26653171 2016
606
In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria. 61
26645269 2016
607
I.V. minocycline revisited for infections caused by multidrug-resistant organisms. 61
26896499 2016
608
Prophylactic removal and microbiological evaluation of calcified plaques after pterygium surgery. 61
26666234 2016
609
[Prolonged culture in a humid chamber increases the yields of pathogenic bacteria from the respiratory tract samples of patients suffering from cystic fibrosis]. 61
27476592 2016
610
Central venous catheter-related blood stream infection with pyomyositis due to Stenotrophomonas maltophilia after allogeneic bone marrow transplantation in a patient with aplastic anemia. 61
26918735 2016
611
Genome Sequence of Stenotrophomonas maltophilia Strain SmAs1, Isolated From the Asian Malaria Mosquito Anopheles stephensi. 61
26966198 2016
612
Inoculation of paperboard mill sludge versus mixed culture bacteria for hydrogen production from paperboard mill wastewater. 61
26498965 2016
613
Insights into the degradation of chlorimuron-ethyl by Stenotrophomonas maltophilia D310-3. 61
26363318 2016
614
A Stenotrophomonas maltophilia Strain Evades a Major Caenorhabditis elegans Defense Pathway. 61
26644380 2016
615
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report. 61
26886594 2016
616
Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis. 61
26203598 2016
617
Characteristics of Stenotrophomonas maltophilia bacteremia in children. 61
26139084 2016
618
A Secreted Ankyrin-Repeat Protein from Clinical Stenotrophomonas maltophilia Isolates Disrupts Actin Cytoskeletal Structure. 61
27622948 2016
619
A Pseudo-Outbreak of Pseudomonas putida and Stenotrophomonas maltophilia in a Bronchoscopy Unit. 61
27627819 2016
620
Role of sul2 gene linked to transposase in resistance to trimethoprim/sulfamethoxazole among Stenotrophomonas maltophilia isolates. 61
26522765 2016
621
Stenotrophomonas maltophilia PhoP, a Two-Component Response Regulator, Involved in Antimicrobial Susceptibilities. 61
27159404 2016
622
Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies. 61
27257956 2016
623
Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments. 61
26999818 2016
624
Identification of Electrode Respiring, Hydrocarbonoclastic Bacterial Strain Stenotrophomonas maltophilia MK2 Highlights the Untapped Potential for Environmental Bioremediation. 61
28018304 2016
625
Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China. 61
27310255 2016
626
Inactivation of SmeSyRy Two-Component Regulatory System Inversely Regulates the Expression of SmeYZ and SmeDEF Efflux Pumps in Stenotrophomonas maltophilia. 61
27513575 2016
627
Characteristics of Aspergillus fumigatus in Association with Stenotrophomonas maltophilia in an In Vitro Model of Mixed Biofilm. 61
27870863 2016
628
Surveillance of Dihydropteroate Synthase Genes in Stenotrophomonas maltophilia by LAMP: Implications for Infection Control and Initial Therapy. 61
27833606 2016
629
Genomic Potential of Stenotrophomonas maltophilia in Bioremediation with an Assessment of Its Multifaceted Role in Our Environment. 61
27446008 2016
630
Longitudinal Metagenomic Analysis of Hospital Air Identifies Clinically Relevant Microbes. 61
27482891 2016
631
Genome Sequence of Type Strains of Genus Stenotrophomonas. 61
27014232 2016
632
Physicochemical and Antibacterial Properties of Chitosan Extracted from Waste Shrimp Shells. 61
27478443 2016
633
Isolation and Characterization of α-Endosulfan Degrading Bacteria from the Microflora of Cockroaches. 61
27281995 2016
634
Engineering broad-spectrum digestion of polyuronides from an exolytic polysaccharide lyase. 61
26913076 2016
635
Antibacterial Activity of Salvadora persica L. (Miswak) Extracts against Multidrug Resistant Bacterial Clinical Isolates. 61
26904146 2016
636
Microbial Diversity in the Early In Vivo-Formed Dental Biofilm. 61
26746720 2016
637
Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey. 61
27499852 2016
638
Metagenomic analysis of medicinal Cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests. 61
27853518 2016
639
Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms. 61
27703329 2016
640
Prevalence, risk factors and molecular epidemiology of highly resistant gram negative rods in hospitalized patients in the Dutch region Kennemerland. 61
26962447 2016
641
Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus. 61
27861524 2016
642
[Stenotrophomonas maltophilia as the cause of ventilator-associated pneumonia in a female patient with toxic epidermal necrolysis and Clostridium colitis: time for off-label tigecycline?] 61
27690475 2016
643
Fatal hemorrhagic pneumonia: Don't forget Stenotrophomonas maltophilia. 61
27358764 2016
644
Genotypic and Phenotypic Characterization of Stenotrophomonas maltophilia Strains from a Pediatric Tertiary Care Hospital in Serbia. 61
27798695 2016
645
Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections. 61
26859493 2016
646
Insights into Cystic Fibrosis Polymicrobial Consortia: The Role of Species Interactions in Biofilm Development, Phenotype, and Response to In-Use Antibiotics. 61
28133457 2016
647
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient. 61
27746770 2016
648
Treatment of Polymicrobial Osteomyelitis with Ceftolozane-Tazobactam: Case Report and Sensitivity Testing of Isolates. 61
27437155 2016
649
Fournier's gangrene (necrotising fasciitis) complicated by renal and respiratory insufficiency: a case report. 61
26762496 2016
650
A Pilot Study of Quantitative Loop-mediated Isothermal Amplification-guided Target Therapies for Hospital-acquired Pneumonia. 61
26830989 2016
651
High-rate biological denitrification in the cyclic rotating-bed biological reactor: Effect of COD/NO3(-), nitrate concentration and salinity and the phylogenetic analysis of denitrifiers. 61
26369277 2015
652
Bacteria associated with Amblyomma cajennense tick eggs. 61
26537602 2015
653
Fatty acid hydration activity of a recombinant Escherichia coli-based biocatalyst is improved through targeting the oleate hydratase into the periplasm. 61
26429801 2015
654
Whole-Genome Sequence of Stenotrophomonas maltophilia ZBG7B Reveals Its Biotechnological Potential. 61
26659682 2015
655
Mechanisms of antimicrobial resistance in Gram-negative bacilli. 61
26261001 2015
656
Molecular characterization of midgut microbiota of Aedes albopictus and Aedes aegypti from Arunachal Pradesh, India. 61
26684012 2015
657
Antimicrobial evaluation of quaternary ammonium polyethyleneimine nanoparticles against clinical isolates of pathogenic bacteria. 61
26647809 2015
658
Whole-genome sequencing identifies emergence of a quinolone resistance mutation in a case of Stenotrophomonas maltophilia bacteremia. 61
26324280 2015
659
Interplay among membrane-bound lytic transglycosylase D1, the CreBC two-component regulatory system, the AmpNG-AmpDI-NagZ-AmpR regulatory circuit, and L1/L2 β-lactamase expression in Stenotrophomonas maltophilia. 61
26282431 2015
660
Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study. 61
26559260 2015
661
Stenotrophomonas maltophilia keratitis treated with trimethoprim-sulfamethoxazole. 61
26008926 2015
662
Genome Sequence of a Multidrug-Resistant Strain of Stenotrophomonas maltophilia with Carbapenem Resistance, Isolated from King Abdullah Medical City, Makkah, Saudi Arabia. 61
26472828 2015
663
Draft Genome Sequences of Acinetobacter parvus CM11, Acinetobacter radioresistens CM38, and Stenotrophomonas maltophilia BR12, Isolated from Murine Proximal Colonic Tissue. 61
26472823 2015
664
Type II Secretion-Dependent Degradative and Cytotoxic Activities Mediated by Stenotrophomonas maltophilia Serine Proteases StmPr1 and StmPr2. 61
26169274 2015
665
Antimicrobial susceptibility pattern of Burkholderia cepacia complex & Stenotrophomonas maltophilia over six years (2007-2012). 61
26609043 2015
666
Regulation of Smqnr expression by SmqnrR is strain-specific in Stenotrophomonas maltophilia. 61
26174722 2015
667
Low Prevalence of Carbapenem-Resistant Bacteria in River Water: Resistance Is Mostly Related to Intrinsic Mechanisms. 61
26430939 2015
668
Development and Validation of an HPLC-UV Assay to Quantify Plasma Levels of Sulfametrol: A Preferential Antibiotic in Children. 61
25830929 2015
669
A novel salt-tolerant chitobiosidase discovered by genetic screening of a metagenomic library derived from chitin-amended agricultural soil. 61
26040993 2015
670
Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation. 61
25856407 2015
671
Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms. 61
26115679 2015
672
The isolation and characterization of two Stenotrophomonas maltophilia bacteriophages capable of cross-taxonomic order infectivity. 61
26335566 2015
673
Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary. 61
26551572 2015
674
Prevalence of Smqnr and plasmid-mediated quinolone resistance determinants in clinical isolates of Stenotrophomonas maltophilia from Japan: novel variants of Smqnr. 61
26110061 2015
675
Real-time monitoring of antimicrobial use density to reduce antimicrobial resistance through the promotion of antimicrobial heterogeneity in a haematology/oncology unit. 61
26071518 2015
676
Evaluation of the Quality of Reprocessing of Gastrointestinal Endoscopes. 61
26022365 2015
677
Hemodialysis catheter-related bacteremia caused by Stenotrophomonas maltophilia. 61
26628804 2015
678
Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India. 61
25781206 2015
679
Correction for Huang et al., NagZ-Dependent and NagZ-Independent Mechanisms for β-Lactamase Expression in Stenotrophomonas maltophilia. 61
26185274 2015
680
Functional properties of the major outer membrane protein in Stenotrophomonas maltophilia. 61
26224456 2015
681
Comparative Genomics of Environmental and Clinical Stenotrophomonas maltophilia Strains with Different Antibiotic Resistance Profiles. 61
26276674 2015
682
Stenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia. 61
26468367 2015
683
Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. 61
26061914 2015
684
The efflux pump SmeDEF contributes to trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia. 61
25918144 2015
685
The SmeYZ efflux pump of Stenotrophomonas maltophilia contributes to drug resistance, virulence-related characteristics, and virulence in mice. 61
25918140 2015
686
Sputum induction improves detection of pathogens in children with cystic fibrosis. 61
25565628 2015
687
Increased Prevalence and Resistance of Important Pathogens Recovered from Respiratory Specimens of Cystic Fibrosis Patients During a Decade. 61
25851069 2015
688
Degradation of abamectin by newly isolated Stenotrophomonas maltophilia ZJB-14120 and characterization of its abamectin-tolerance mechanism. 61
25957243 2015
689
Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital. 61
24239064 2015
690
Purification, characterization, and gene cloning of a chitinase from Stenotrophomonas maltophilia N4. 61
25684706 2015
691
Draft Genome Sequence of Stenotrophomonas maltophilia Strain UV74 Reveals Extensive Variability within Its Genomic Group. 61
26067959 2015
692
Detection and location of OP-degrading activity: A model to integrate education and research. 61
25863354 2015
693
Inconclusive diagnosis of cystic fibrosis after newborn screening. 61
25963003 2015
694
Use of loop-mediated isothermal amplification to detect six groups of pathogens causing secondary lower respiratory bacterial infections in horses. 61
25846404 2015
695
High-level quinolone resistance is associated with the overexpression of smeVWX in Stenotrophomonas maltophilia clinical isolates. 61
25753190 2015
696
Epidemiology and outcomes of Stenotrophomonas maltophilia and Burkholderia cepacia infections among trauma patients of India: a five year experience. 61
28989412 2015
697
Biotransformation of oleic acid into 10-ketostearic acid by recombinant Corynebacterium glutamicum-based biocatalyst. 61
25700814 2015
698
Characterization of bacteria degrading 3-hydroxy palmitic acid methyl ester (3OH-PAME), a quorum sensing molecule of Ralstonia solanacearum. 61
25580768 2015
699
Analysis of microbial load on surgical instruments after clinical use and following manual and automated cleaning. 61
25952049 2015
700
Sensitive, resistant and multi-drug resistant Acinetobacter baumanii at Saudi Arabia hospital eastern region. 61
26004714 2015
701
Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms. 61
25985315 2015
702
Haemorrhagic pneumonia caused by Stenotrophomonas maltophilia in two newborns. 61
25989175 2015
703
Genetic Manipulation of Stenotrophomonas maltophilia. 61
26344220 2015
704
Draft Genome Sequence of the Biofilm-Forming Stenotrophomonas maltophilia Strain 53. 61
25883296 2015
705
Characterization of a genomic island in Stenotrophomonas maltophilia that carries a novel floR gene variant. 61
25477328 2015
706
Impact of pathogen-directed antimicrobial therapy for ventilator-associated pneumonia in trauma patients on charges and recurrence. 61
25572796 2015
707
Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis. 61
25830686 2015
708
Conjunctival flora of clinically normal and diseased turtles and tortoises. 61
25889261 2015
709
The sul1 gene in Stenotrophomonas maltophilia with high-level resistance to trimethoprim/sulfamethoxazole. 61
25729729 2015
710
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 61
25592000 2015
711
Purification and characterization of novel organic solvent tolerant 98kDa alkaline protease from isolated Stenotrophomonas maltophilia strain SK. 61
25462807 2015
712
Isolation of Vermamoeba vermiformis and associated bacteria in hospital water. 61
25697664 2015
713
Characterization of bacterial community of raw milk from dairy cows during subacute ruminal acidosis challenge by high-throughput sequencing. 61
24961605 2015
714
Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience. 61
25293429 2015
715
Late Stenotrophomonas maltophilia pacemaker infective endocarditis. 61
25722039 2015
716
Rapid automated microscopy for microbiological surveillance of ventilator-associated pneumonia. 61
25585163 2015
717
Counterion-activated nanoactuator: reversibly switchable killing/releasing bacteria on polycation brushes. 61
25608105 2015
718
Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation. 61
25580541 2015
719
Introducing a salt bridge into the lipase of Stenotrophomonas maltophilia results in a very large increase in thermal stability. 61
25257598 2015
720
Draft Genome Sequence of Stenotrophomonas maltophilia Strain B418, a Promising Agent for Biocontrol of Plant Pathogens and Root-Knot Nematode. 61
25700397 2015
721
Genome-wide identification of genes necessary for biofilm formation by nosocomial pathogen Stenotrophomonas maltophilia reveals that orphan response regulator FsnR is a critical modulator. 61
25480754 2015
722
The contribution of class 1 integron to antimicrobial resistance in Stenotrophomonas maltophilia. 61
25243757 2015
723
In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives. 61
25456893 2015
724
Granulation, control of bacterial contamination, and enhanced lipid accumulation by driving nutrient starvation in coupled wastewater treatment and Chlorella regularis cultivation. 61
25520170 2015
725
A rapid culture independent methodology to quantitatively detect and identify common human bacterial pathogens associated with contaminated high purity water. 61
25888294 2015
726
Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies. 61
25643274 2015
727
Complementary treatment of contact lens-induced corneal ulcer using honey: a case report. 61
25278429 2015
728
Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital. 61
25715262 2015
729
Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations. 61
25887489 2015
730
Antibiogram of Stenotrophomonas maltophilia Isolated From Nkonkobe Municipality, Eastern Cape Province, South Africa. 61
25789125 2015
731
Identification and characterization of a serious multidrug resistant Stenotrophomonas maltophilia strain in China. 61
25654114 2015
732
Decoding the genetic and functional diversity of the DSF quorum-sensing system in Stenotrophomonas maltophilia. 61
26284046 2015
733
Stenotrophomonas maltophilia responds to exogenous AHL signals through the LuxR solo SmoR (Smlt1839). 61
26029670 2015
734
In vitro interaction of Stenotrophomonas maltophilia with human monocyte-derived dendritic cells. 61
26236302 2015
735
Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study. 61
26208218 2015
736
Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative Bacteria. 61
26635765 2015
737
Phenotypic Heterogeneity Affects Stenotrophomonas maltophilia K279a Colony Morphotypes and β-Lactamase Expression. 61
26696982 2015
738
Expression and Functions of CreD, an Inner Membrane Protein in Stenotrophomonas maltophilia. 61
26698119 2015
739
Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. 61
26388847 2015
740
Iron is a signal for Stenotrophomonas maltophilia biofilm formation, oxidative stress response, OMPs expression, and virulence. 61
26388863 2015
741
The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in Stenotrophomonas maltophilia. 61
25926824 2015
742
[Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates]. 61
25706729 2015
743
A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia. 61
26167850 2015
744
Friends or foes: can we make a distinction between beneficial and harmful strains of the Stenotrophomonas maltophilia complex? 61
25873912 2015
745
The Identification of Stenotrophomonas maltophilia Contamination in Ultrasound Endoscopes and Reproduction of Decontamination Failure by Deliberate Soiling Tests. 61
25925975 2015
746
Regulation by SoxR of mfsA, Which Encodes a Major Facilitator Protein Involved in Paraquat Resistance in Stenotrophomonas maltophilia. 61
25915643 2015
747
Predictive Studies Suggest that the Risk for the Selection of Antibiotic Resistance by Biocides Is Likely Low in Stenotrophomonas maltophilia. 61
26201074 2015
748
Molecular epidemiology and antimicrobial susceptibility of Stenotrophomonas maltophilia in a Bulgarian university hospital over a 5-year period (2007-2012). 61
26198085 2015
749
The inactivation of RNase G reduces the Stenotrophomonas maltophilia susceptibility to quinolones by triggering the heat shock response. 61
26539164 2015
750
Effects of the joint exposure of decabromodiphenyl ether and tetrabromobisphenol A on soil bacterial community structure. 61
25106514 2015
751
Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology. 61
25640914 2015
752
Fluids for continuous renal replacement therapy--an evaluation of microbial integrity. 61
25633890 2015
753
Multi-channel microfluidic biosensor platform applied for online monitoring and screening of biofilm formation and activity. 61
25706987 2015
754
Rahnella aquatilis Sepsis in a Premature Newborn. 61
26090257 2015
755
A Case of Sinusitis Caused by Schizophyllum Commune and Bacteria in Acute Myelocytic Leukemia. 61
26732008 2015
756
EPS production and bioremoval of heavy metals by mixed and pure bacterial cultures isolated from Ankara Stream. 61
26524439 2015
757
Biogenic selenium and tellurium nanoparticles synthesized by environmental microbial isolates efficaciously inhibit bacterial planktonic cultures and biofilms. 61
26136728 2015
758
Effect of carbon on whole-biofilm metabolic response to high doses of streptomycin. 61
26441887 2015
759
[Orbital cellulitis with concomitant bacteraemia (Stenotrophomonas maltophilia) as a complication of an intraorbital foreign body--a case report and literature review]. 61
26638549 2015
760
Pathogen distribution and drug resistance in a burn ward: a three-year retrospective analysis of a single center in China. 61
26770555 2015
761
Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI. 61
25789262 2015
762
Prevalence of opportunistic infections in HIV-positive patients in Bahrain: a four-year review (2009-2013). 61
25596573 2015
763
Severe ovarian hyperstimulation syndrome complicated by Stenotrophomonas maltophilia peritonitis: a case report and literature review. 61
25948367 2015
764
In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 61
25348526 2015
765
Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis. 61
25995646 2015
766
Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum. 61
25441256 2015
767
Post-cataract endophthalmitis caused by multidrug-resistant Stenotrophomonas maltophilia: clinical features and risk factors. 61
25618260 2015
768
Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients. 61
26401445 2015
769
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm. 61
26441885 2015
770
Isolation and Identification of Plant Growth Promoting Rhizobacteria from Cucumber Rhizosphere and Their Effect on Plant Growth Promotion and Disease Suppression. 61
26869996 2015
771
Lung transplantation after endoscopic lung volume reduction. 61
26138023 2015
772
Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia. 61
26175724 2015
773
Stenotrophomonas maltophilia with histopathological features mimicking cutaneous gamma/delta T-cell lymphoma. 61
25462188 2015
774
Real-time monitoring of hydrogen cyanide (HCN) and ammonia (NH₃) emitted by Pseudomonas aeruginosa. 61
25634638 2015
775
Clinical ineffectiveness of latamoxef for Stenotrophomonas maltophilia infection. 61
26527890 2015
776
In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria. 61
25523727 2014
777
Bacterial degradation of naproxen--undisclosed pollutant in the environment. 61
25026371 2014
778
Pyrene removal and transformation by joint application of alfalfa and exogenous microorganisms and their influence on soil microbial community. 61
25232990 2014
779
Characterizing novel thermophilic amylase producing bacteria from taptapani hot spring, odisha, India. 61
25741425 2014
780
Developing a Method for Reporting Patient Harm Due to Antimicrobial Shortages. 61
25234281 2014
781
Combination of photoreactor and packed bed bioreactor for the removal of ethyl violet from wastewater. 61
25259784 2014
782
Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary. 61
25551459 2014
783
MacABCsm, an ABC-type tripartite efflux pump of Stenotrophomonas maltophilia involved in drug resistance, oxidative and envelope stress tolerances and biofilm formation. 61
25139838 2014
784
Stenotrophomonas maltophilia and Vermamoeba vermiformis relationships: bacterial multiplication and protection in amoebal-derived structures. 61
25463386 2014
785
Highly efficient transformation of Stenotrophomonas maltophilia S21, an environmental isolate from soil, by electroporation. 61
25300664 2014
786
Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options. 61
25371512 2014
787
Stenotrophomonas maltophilia in Lower Respiratory Tract Infections. 61
25653948 2014
788
In vitro activity of colistin against Stenotrophomonas maltophilia. 61
27873694 2014
789
Susceptibility of Stenotrophomonas maltophilia clinical isolates to antibiotics and contact lens multipurpose disinfecting solutions. 61
25468893 2014
790
Delineation of Stenotrophomonas maltophilia isolates from cystic fibrosis patients by fatty acid methyl ester profiles and matrix-assisted laser desorption/ionization time-of-flight mass spectra using hierarchical cluster analysis and principal component analysis. 61
25266870 2014
791
Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin. 61
25134721 2014
792
Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity. 61
25165124 2014
793
Preventing microbial colonisation of catheters: antimicrobial and antibiofilm activities of cellobiose dehydrogenase. 61
25176584 2014
794
Evaluation of a new monochloramine generation system for controlling Legionella in building hot water systems. 61
25333430 2014
795
Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi metallo-β-lactamase-1 (NDM-1). 61
25048031 2014
796
Non-fermentative gram-negative bacteria in hospital tap water and water used for haemodialysis and bronchoscope flushing: prevalence and distribution of antibiotic resistant strains. 61
25173861 2014
797
Exploring nicotinamide cofactor promiscuity in NAD(P)H-dependent flavin containing monooxygenases (FMOs) using natural variation within the phosphate binding loop. Structure and activity of FMOs from Cellvibrio sp. BR and Pseudomonas stutzeri NF13. 61
25383040 2014
798
Antibiotic-resistant gram-negative bacterial infections in patients with cancer. 61
25352627 2014
799
Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin-1Pa. 61
25241629 2014
800
Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa. 61
25447194 2014
801
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. 61
25383937 2014
802
Stenotrophomonas maltophilia: an emerging pathogen in dialysis units. 61
25102909 2014
803
Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations. 61
24588423 2014
804
Stenotrophomonas maltophilia interferes via the DSF-mediated quorum sensing system with Candida albicans filamentation and its planktonic and biofilm modes of growth. 61
25576410 2014
805
Identification of a novel 6'-N-aminoglycoside acetyltransferase, AAC(6')-Iak, from a multidrug-resistant clinical isolate of Stenotrophomonas maltophilia. 61
25092711 2014
806
Novel cyclic di-GMP effectors of the YajQ protein family control bacterial virulence. 61
25329577 2014
807
Blood infections in patients treated at transplantation wards of a clinical hospital in Warsaw. 61
25380873 2014
808
Characterization of environmental CTX-M-15-producing Stenotrophomonas maltophilia. 61
25092701 2014
809
Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia. 61
24781003 2014
810
Complete Genome Sequence of Stenotrophomonas maltophilia Type Strain 810-2 (ATCC 13637). 61
25258273 2014
811
[Efficacy of tigecycline in treating severe infections of patients with hematological diseases]. 61
25511594 2014
812
Synergistic interactions in mixed-species biofilms of pathogenic bacteria from the respiratory tract. 61
25467269 2014
813
Bacterial constituents of indoor air in a high throughput building in the tropics. 61
25382482 2014
814
MALDI-TOF: a useful tool for laboratory identification of uncommon glucose non-fermenting Gram-negative bacteria associated with cystic fibrosis. 61
24980571 2014
815
Clinical characteristics and risk factors of infections caused by Stenotrophomonas maltophilia in a hospital in northwest China. 61
25116665 2014
816
A function of SmeDEF, the major quinolone resistance determinant of Stenotrophomonas maltophilia, is the colonization of plant roots. 61
24837376 2014
817
[A retrospective clinicopathological study of aspiration pneumonia in the elderly]. 61
25351266 2014
818
[Prevalence and features of pathogenic bacteria in the department of hematology without bone marrow transplantation in Peking Union Medical College Hospital from 2010 to 2012]. 61
25176215 2014
819
[Pathogenic analysis of ventilator-associated pneumonia in the pediatric intensive care unit in high-altitude areas]. 61
25140768 2014
820
Stenotrophomonas maltophilia: rare cause of meningitis. 61
25252064 2014
821
Two different rpf clusters distributed among a population of Stenotrophomonas maltophilia clinical strains display differential diffusible signal factor production and virulence regulation. 61
24769700 2014
822
Biosorption and biodegradation of triphenyltin by Stenotrophomonas maltophilia and their influence on cellular metabolism. 61
24866561 2014
823
Clinical factors associated with acquisition of resistance to levofloxacin in Stenotrophomonas maltophilia. 61
24954328 2014
824
Stenotrophomonas maltophilia endophthalmitis caused by surgical equipment contamination: an emerging nosocomial infection. 61
25667741 2014
825
Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010. 61
24777091 2014
826
Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012. 61
24458500 2014
827
Malakoplakia of liver: report of two cases. 61
24755510 2014
828
Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: molecular diversity, mutation frequency and antibiotic resistance. 61
24836944 2014
829
Genomic characterization and integrative properties of phiSMA6 and phiSMA7, two novel filamentous bacteriophages of Stenotrophomonas maltophilia. 61
24327089 2014
830
Synthesis, in vitro antimicrobial and cytotoxic activities of novel pyrimidine-benzimidazol combinations. 61
24798098 2014
831
[Isolation and characterization of two bacteria with heavy metal resistance and phosphate solubilizing capability]. 61
25158515 2014
832
Insight into the role of substrate-binding residues in conferring substrate specificity for the multifunctional polysaccharide lyase Smlt1473. 61
24808176 2014
833
Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012). 61
24856078 2014
834
Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis. 61
24667348 2014
835
Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases. 61
24535696 2014
836
Stenotrophomonas maltophilia infection during allogeneic hematopoietic stem cell transplantation: a single-center experience. 61
24628242 2014
837
Draft Genome Sequence of Stenotrophomonas maltophilia Strain M30, Isolated from a Chronic Pressure Ulcer in an Elderly Patient. 61
24926059 2014
838
Chronic dacryocystitis secondary to Stenotrophomonas maltophilia and Staphylococcus aureus mixed infection. 61
24951597 2014
839
Evaluation of treatment outcomes for Stenotrophomonas maltophilia bacteraemia. 61
24627266 2014
840
Interplay between intrinsic and acquired resistance to quinolones in Stenotrophomonas maltophilia. 61
24447641 2014
841
Draft Genome Sequence of Stenotrophomonas maltophilia SeITE02, a Gammaproteobacterium Isolated from Selenite-Contaminated Mining Soil. 61
24812214 2014
842
In vitro activity of tigecycline against isolates collected from complicated skin and skin structure infections and intra-abdominal infections in Africa and Middle East countries: TEST 2007-2012. 61
24582580 2014
843
Persistence of microbial communities including Pseudomonas aeruginosa in a hospital environment: a potential health hazard. 61
24885173 2014
844
A Patient Presenting with Cholangitis due to Stenotrophomonas Maltophilia and Pseudomonas Aeruginosa Successfully Treated with Intrabiliary Colistine. 61
25002957 2014
845
[Treatment of Stenotrophomonas maltophilia meningoencephalitis with intraventricular colistin]. 61
24951912 2014
846
Rapid identification of Stenotrophomonas maltophilia by peptide nucleic acid fluorescence in situ hybridization. 61
25356348 2014
847
Influence of co-existed benzo[a]pyrene and copper on the cellular characteristics of Stenotrophomonas maltophilia during biodegradation and transformation. 61
24603491 2014
848
Images in emergency medicine. An unusual swelling at the pacemaker pocket site. Pacemaker pocket infection caused by Stenotrophomonas maltophilia. 61
24655444 2014
849
[Investigation of integrons, sul1-2 and dfr genes in trimethoprim-sulfametoxazole-resistant Stenotrophomonas maltophilia strains isolated from clinical samples]. 61
24819258 2014
850
Effects of a sulfonylurea herbicide on the soil bacterial community. 61
24420563 2014
851
Are community environmental surfaces near hospitals reservoirs for gram-negative nosocomial pathogens? 61
24679558 2014
852
An L-glucitol oxidizing dehydrogenase from Bradyrhizobium japonicum USDA 110 for production of D-sorbose with enzymatic or electrochemical cofactor regeneration. 61
24061413 2014
853
Bacterial strains isolated from PCB-contaminated sediments and their use for bioaugmentation strategy in microcosms. 61
23553615 2014
854
Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea. 61
24462178 2014
855
Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012. 61
24630306 2014
856
Epidemiology and antimicrobial resistance among commonly encountered bacteria associated with infections and colonization in intensive care units in a university-affiliated hospital in Shanghai. 61
23357606 2014
857
Clinical significance of surveillance culture in liver transplant recipients. 61
24767358 2014
858
Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria. 61
24257317 2014
859
Predictors and outcome of low initial forced expiratory volume in 1 second measurement in children with cystic fibrosis. 61
24418473 2014
860
Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. 61
24696136 2014
861
Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis. 61
24725655 2014
862
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact. 61
24573013 2014
863
Antifungal activity of Stenotrophomonas maltophilia in Stomoxys calcitrans larvae. 61
25054498 2014
864
Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii. 61
24447250 2014
865
Draft Genome Sequence of Stenotrophomonas maltophilia Strain 5BA-I-2, a Soil Isolate and a Member of a Phylogenetically Basal Lineage. 61
24604648 2014
866
Bacterial resistance control on mineral surfaces of hydroxyapatite and human teeth via surface charge-driven antifouling coatings. 61
24513459 2014
867
Crystallization of the N-terminal regulatory domain of the enhancer-binding protein FleQ from Stenotrophomonas maltophilia. 61
24598919 2014
868
First report of digital skin ulcer with Stenotrophomonas maltophilia infection in an immunocompetent patient. 61
24632983 2014
869
Effect of moxifloxacin on survival, lipid peroxidation and inflammation in immunosuppressed rats with soft tissue infection caused by Stenotrophomonas maltophilia. 61
24372798 2014
870
Virulence genes in clinical and environmental Stenotrophomas maltophilia isolates: a genome sequencing and gene expression approach. 61
24530922 2014
871
Extracellular enzyme profiling of Stenotrophomonas maltophilia clinical isolates. 61
24448556 2014
872
Laboratory culture and maintenance of Stenotrophomonas maltophilia. 61
24510848 2014
873
Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections. 61
23040236 2014
874
Carbazole angular dioxygenation and mineralization by bacteria isolated from hydrocarbon-contaminated tropical African soil. 61
24728574 2014
875
Microbe associated molecular patterns from rhizosphere bacteria trigger germination and Papaver somniferum metabolism under greenhouse conditions. 61
24296249 2014
876
Host-defense peptides with therapeutic potential from skin secretions of frogs from the family pipidae. 61
24434793 2014
877
Isolation and characterization of phenol utilizing bacteria from industrial effluent-contaminated soil and kinetic evaluation of their biodegradation potential. 61
24117085 2014
878
Contribution of hot spring bacterial consortium in cadmium and lead bioremediation through quadratic programming model. 61
24333714 2014
879
The influence of bioaugmentation and biosurfactant addition on bioremediation efficiency of diesel-oil contaminated soil: feasibility during field studies. 61
24291585 2014
880
Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. 61
24165191 2014
881
Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species. 61
25375244 2014
882
A linkage between SmeIJK efflux pump, cell envelope integrity, and σE-mediated envelope stress response in Stenotrophomonas maltophilia. 61
25390933 2014
883
Degradation potential of protocatechuate 3,4-dioxygenase from crude extract of Stenotrophomonas maltophilia strain KB2 immobilized in calcium alginate hydrogels and on glyoxyl agarose. 61
24693536 2014
884
Protocatechuate 3,4-dioxygenase: a wide substrate specificity enzyme isolated from Stenotrophomonas maltophilia KB2 as a useful tool in aromatic acid biodegradation. 61
24970342 2014
885
Genomic sequence of temperate phage Smp131 of Stenotrophomonas maltophilia that has similar prophages in xanthomonads. 61
24472137 2014
886
Stenotrophomonas maltophilia Pseudo-outbreak at a University Hospital Bronchoscopy Unit in Turkey. 61
25303196 2014
887
The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophilia. 61
25285537 2014
888
A polysaccharide lyase from Stenotrophomonas maltophilia with a unique, pH-regulated substrate specificity. 61
24257754 2014
889
Prevalence and detection of Stenotrophomonas maltophilia carrying metallo-β-lactamase blaL1 in Beijing, China. 61
25538701 2014
890
Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia? 61
24126583 2014
891
Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. 61
24145530 2014
892
SmeOP-TolCSm efflux pump contributes to the multidrug resistance of Stenotrophomonas maltophilia. 61
24395237 2014
893
antibacTR: dynamic antibacterial-drug-target ranking integrating comparative genomics, structural analysis and experimental annotation. 61
24438389 2014
894
The use of colistin in critically ill children in a pediatric intensive care unit. 61
24346607 2014
895
Non-cephalosporin-susceptible, glucose non-fermentative Gram-negative bacilli meningitis in post-neurosurgical adults: clinical characteristics and therapeutic outcome. 61
24287342 2014
896
High-dosage tigecycline for Stenotrophomonas maltophilia bacteremia. 61
25189974 2014
897
Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm. 61
24690894 2014
898
Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. 61
25202682 2014
899
Stenotrophomonas maltophilia endogenous endophthalmitis: clinical presentation, antibiotic susceptibility, and outcomes. 61
25170244 2014
900
Recurrent Stenotrophomonas maltophilia bacteremia after iliac crest bone graft harvest. 61
25088888 2014
901
Dengue co-infection in a blood stream infection caused by Stenotrophomonas maltophilia: A case report. 61
25550715 2014
902
An 8-year survey of strains identified in blood cultures in a clinical haematology unit. 61
23826912 2014
903
The cystic fibrosis lung microbiome. 61
24437409 2014
904
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens. 61
25517897 2014
905
Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children. 61
23806622 2014
906
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 61
24586389 2014
907
Evaluation of humoral immune response to nosocomial pathogen and functional status in elderly patients with sepsis. 61
23998496 2014
908
New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen. 61
24308713 2014
909
Phenotypic and Genetic Characterization of Carbapenemase and ESBLs Producing Gram-negative Bacteria (GNB) Isolated from Patients with Cystic Fibrosis (CF) in Tehran Hospitals. 61
24596716 2014
910
Purification and identification of trichloroethylene induced proteins from Stenotrophomonas maltophilia PM102 by immuno-affinity-chromatography and MALDI-TOF Mass spectrometry. 61
23741645 2013
911
Combination therapy for Gram-negative bacteria: what is the evidence? 61
24168069 2013
912
Identification and discrimination of bacteria using Fourier transform infrared spectroscopy. 61
23973597 2013
913
Assessing the xylanolytic bacterial diversity during the malting process. 61
24010623 2013
914
Identification and susceptibility to multipurpose disinfectant solutions of bacteria isolated from contact lens storage cases of patients with corneal infiltrative events. 61
23466175 2013
915
An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties. 61
24172540 2013
916
Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis. 61
23706828 2013
917
Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients. 61
23757360 2013
918
Outbreak of Stenotrophomonas maltophilia on an intensive care unit. 61
24148363 2013
919
Adhesive properties of predominant bacteria in raw cow's milk to bovine mammary gland epithelial cells. 61
23532507 2013
920
Involvement of mutation in ampD I, mrcA, and at least one additional gene in β-lactamase hyperproduction in Stenotrophomonas maltophilia. 61
23979761 2013
921
Screening, purification and characterization of a novel cold-active and organic solvent-tolerant lipase from Stenotrophomonas maltophilia CGMCC 4254. 61
24050922 2013
922
Modification of surface and enzymatic properties of Achromobacter denitrificans and Stenotrophomonas maltophilia in association with diesel oil biodegradation enhanced with alkyl polyglucosides. 61
23777790 2013
923
Characterization of a major facilitator superfamily (MFS) tripartite efflux pump EmrCABsm from Stenotrophomonas maltophilia. 61
23794602 2013
924
Chitooligosaccharides are converted to N-acetylglucosamine by N-acetyl-β-hexosaminidase from Stenotrophomonas maltophilia. 61
23965017 2013
925
Smqnr variants in clinical isolates of Stenotrophomonas maltophilia in Brazil. 61
24213195 2013
926
Stenotrophomonas maltophilia: pathogenesis model using Caenorhabditis elegans. 61
23988629 2013
927
Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Pneumonia in a Neonate. 61
24357872 2013
928
Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France. 61
23719852 2013
929
Additional observations and notes on the natural history of the prairie rattlesnake (Crotalus viridis) in Colorado. 61
24331557 2013
930
[Lower respiratory tract infections related to Stenotrophomonas maltophilia and Acinetobacter baumannii]. 61
23583504 2013
931
Nonfermenting Gram-negative Bacilli other than Pseudomonas aeruginosa and Acinetobacter Spp. Causing Respiratory Tract Infections in a Tertiary Care Center. 61
24672175 2013
932
Stenotrophomonas, Mycobacterium, and Streptomyces in home dust and air: associations with moldiness and other home/family characteristics. 61
23397905 2013
933
Degradation of multiwall carbon nanotubes by bacteria. 61
23859846 2013
934
Whole-genome sequences of five oyster-associated bacteria show potential for crude oil hydrocarbon degradation. 61
24092793 2013
935
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa. 61
23696619 2013
936
The impact of respiratory tract infections on the nutritional state of children with cystic fibrosis. 61
24502062 2013
937
An evaluation of microbial and chemical contamination sources related to the deterioration of tap water quality in the household water supply system. 61
24018837 2013
938
Biodegradation of phenanthrene in bioaugmented microcosm by consortium ASP developed from coastal sediment of Alang-Sosiya ship breaking yard. 61
23906474 2013
939
Antimicrobial activity of novel nanostructured Cu-SiO2 coatings prepared by chemical vapour deposition against hospital related pathogens. 61
24007899 2013
940
Bacterial bioeffectors modify bioactive profile and increase isoflavone content in soybean sprouts (Glycine max var Osumi). 61
23918406 2013
941
Characterization of maltocin P28, a novel phage tail-like bacteriocin from Stenotrophomonas maltophilia. 61
23835182 2013
942
Role of the pcm-tolCsm operon in the multidrug resistance of Stenotrophomonas maltophilia. 61
23629016 2013
943
Characterization of three antifungal calcite-forming bacteria, Arthrobacter nicotianae KNUC2100, Bacillus thuringiensis KNUC2103, and Stenotrophomonas maltophilia KNUC2106, derived from the Korean islands, Dokdo and their application on mortar. 61
23727794 2013
944
Production of 10-hydroxy-12,15(Z,Z)-octadecadienoic acid from α-linolenic acid by permeabilized cells of recombinant Escherichia coli expressing the oleate hydratase gene of Stenotrophomonas maltophilia. 61
23690042 2013
945
Stenotrophomonas maltophilia encodes a type II protein secretion system that promotes detrimental effects on lung epithelial cells. 61
23774603 2013
946
[Risk factors and clinical charasteristics of Stenotrophomonas maltophilia bacteremia: a comparison with bacteremia due to other glucose-non fermenters]. 61
24195169 2013
947
Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. 61
23294530 2013
948
[Drug resistance of imipenem-resistant Gram-negative bacilli in coal worker's pneumoconiosis chronic obstructive pulmonary disease patients with lower respiratory tract infection]. 61
24064132 2013
949
Cases of active infective endocarditis in a university hospital during a 10-year period. 61
24601198 2013
950
Correlations between Microbiological Outcomes and Clinical Responses in Patients with Severe Pneumonia. 61
24396629 2013
951
Baby bottle steam sterilizers disinfect home nebulizers inoculated with bacterial respiratory pathogens. 61
23267773 2013
952
Clinical characteristics of Stenotrophomonas maltophilia meningitis in adults: a high incidence in patients with a postneurosurgical state, long hospital staying and antibiotic use. 61
23611735 2013
953
Simple, time saving pulsed-field gel electrophoresis protocol for the typing of Stenotrophomonas maltophilia. 61
23756145 2013
954
Molecular investigation of bacterial communities on the inner and outer surfaces of peripheral venous catheters. 61
23529345 2013
955
Isolation and characterization of alkane degrading bacteria from petroleum reservoir waste water in Iran (Kerman and Tehran provenances). 61
23790464 2013
956
A case of unusual Gram-negative bacilli septic arthritis in an immunocompetent patient. 61
24005465 2013
957
Molecular characterization of 2-chlorobiphenyl degrading Stenotrophomonas maltophilia GS-103. 61
23801320 2013
958
Meningitis due to Stenotrophomonas maltophilia after a Neurosurgical Procedure. 61
24086879 2013
959
Different utilizable substrates have different effects on cometabolic fate of imidacloprid in Stenotrophomonas maltophilia. 61
23053094 2013
960
Biodegradation of wool waste and keratinase production in scale-up fermenter with different strategies by Stenotrophomonas maltophilia BBE11-1. 61
23708787 2013
961
Effects of Agaricus lilaceps fairy rings on soil aggregation and microbial community structure in relation to growth stimulation of western wheatgrass (Pascopyrum smithii) in Eastern Montana rangeland. 61
23455430 2013
962
Bloodstream infection in patients with end-stage renal disease in a teaching hospital in central-western Brazil. 61
23970309 2013
963
External auditory canal microbiology and hearing aid use. 61
23313122 2013
964
High activity catechol 1,2-dioxygenase from Stenotrophomonas maltophilia strain KB2 as a useful tool in cis,cis-muconic acid production. 61
23536173 2013
965
Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli. 61
23507283 2013
966
[Effect of colistin consumption and prevalence of colistin-resistant bacteria]. 61
23965814 2013
967
Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011). 61
23522845 2013
968
[Multiresistant Gram-negative bacterial infections: Enterobacteria, Pseudomonas aeruginosa, Acinetobacter baumannii and other non-fermenting Gram-negative bacilli]. 61
23684390 2013
969
Non healing leg ulcer infected with Stenotrophomonas maltophilia: first reported case from India. 61
22289105 2013
970
Systemic exposure to Pseudomonal bacteria: a potential link between type 1 diabetes and chronic inflammation. 61
22864910 2013
971
[Isolation and identification of rumen bacteria for cellulolytic enzyme production]. 61
23957151 2013
972
Distinct groups and antimicrobial resistance of clinical Stenotrophomonas maltophilia complex isolates from Korea. 61
23429694 2013
973
[Biological characteristics of phage SM1 for Stenotrophomonas maltophilia and its effect in animal infection model]. 61
23801623 2013
974
Genome Sequence of Stenotrophomonas maltophilia Strain AU12-09, Isolated from an Intravascular Catheter. 61
23640378 2013
975
Effects of pathology dyes on Raman bone spectra. 61
23640079 2013
976
Respiratory bacterial infections in cystic fibrosis. 61
23449384 2013
977
A specific polymerase chain reaction method to identify Stenotrophomonas maltophilia. 61
23778655 2013
978
Stenotrophomonas maltophilia strains isolated from a university hospital in Japan: genomic variability and antibiotic resistance. 61
23264453 2013
979
Molecular characterization and ultrastructure of a new amoeba endoparasite belonging to the Stenotrophomonas maltophilia complex. 61
23298539 2013
980
Draft Genome Sequence of Stenotrophomonas maltophilia Strain EPM1, Found in Association with a Culture of the Human Parasite Giardia duodenalis. 61
23599297 2013
981
Stenotrophomonas infection in a patient with glucose-6-phosphate dehydrogenase deficiency. 61
23798908 2013
982
Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria. 61
23566113 2013
983
Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates. 61
23113657 2013
984
Chitinase A from Stenotrophomonas maltophilia shows transglycosylation and antifungal activities. 61
23428818 2013
985
Multiple degradation pathways of phenanthrene by Stenotrophomonas maltophilia C6. 61
23539472 2013
986
Innate immune responses to Stenotrophomonas maltophilia in immunocompromised pediatric patients and the effect of taurolidine. 61
22727544 2013
987
Neonatal listeriosis followed by nosocomial infection. 61
23867680 2013
988
Non healing legs ulcers infected with Stenotrophomonas maltophilia. 61
23648767 2013
989
Antimicrobial activity and clinical effectiveness of sisomicin: an evaluation of the literature (1995-2011). 61
23566151 2013
990
[The experience of applying techniques of molecular genetics in identification of clinical strains Pseudomonas aeruginosa]. 61
23808024 2013
991
AmpG is required for BlaXc beta-lactamase expression in Xanthomonas campestris pv. campestris str. 17. 61
23278458 2013
992
Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. 61
23072320 2013
993
[Methods for extraction of exopolymeric complex in plankton and biofilm growth mode of Stenotrophomonas maltophilia 22M]. 61
23720963 2013
994
Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. 61
23318796 2013
995
Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases. 61
23485438 2013
996
Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients. 61
23430671 2013
997
Frequency of fungi in respiratory samples from Turkish cystic fibrosis patients. 61
22747891 2013
998
Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients. 61
23295930 2013
999
Effect of copper(II) on biodegradation of benzo[a]pyrene by Stenotrophomonas maltophilia. 61
23141841 2013
1000
Influence of metal ions on bioremediation activity of protocatechuate 3,4-dioxygenase from Stenotrophomonas maltophilia KB2. 61
23014843 2013
1001
Nontuberculous mycobacteria, fungi, and opportunistic pathogens in unchlorinated drinking water in The Netherlands. 61
23160134 2013
1002
Investigation of potential rhizospheric isolate for cypermethrin degradation. 61
28324344 2013
1003
Computed tomography features of Stenotrophomonas maltophilia pneumonia in patients with neutropenic fever: report of two cases. 61
23414606 2013
1004
Yersinia enterocolitica and Photorhabdus asymbiotica β-lactamases BlaA are exported by the twin-arginine translocation pathway. 61
23276548 2013
1005
Diversity and antimicrobial properties of lactic acid bacteria isolated from rhizosphere of olive trees and desert truffles of Tunisia. 61
24151598 2013
1006
Emergence of unusual nonfermenting Gram-negative nosocomial pathogens in a Saudi hospital. 61
24270139 2013
1007
Role of the moth fly Clogmia albipunctata (Diptera: Psychodinae) as a mechanical vector of bacterial pathogens in German hospitals. 61
23182212 2013
1008
Detection of extended spectrum β-lactamase in Pseudomonas spp. isolated from two tertiary care hospitals in Bangladesh. 61
23289861 2013
1009
Microbiological investigation of Raphanus sativus L. grown hydroponically in nutrient solutions contaminated with spoilage and pathogenic bacteria. 61
23290244 2013
1010